======================================================================
HIERARCHICAL REGRESSION ANALYSIS SUMMARY
======================================================================

Model Structure:
  Model 0: age + gender
  Model 1: Model 0 + DASS-21 (depression, anxiety, stress)
  Model 2: Model 1 + UCLA loneliness
  Model 3: Model 2 + UCLA x Gender interaction

----------------------------------------------------------------------

Outcome: PRP Delay Effect (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0074, p = 0.651
  Step 2 (UCLA):        Delta R^2 = 0.0103, p = 0.142 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0130, p = 0.122 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 21.9447, SE = 14.8820, t = 1.47, p = 0.140

UCLA x Gender Interaction (Model 3):
  beta = 36.5674, SE = 23.5211, p = 0.120

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 16.6294, p = 0.366
  Male (n=82):   beta = 18.8604, p = 0.430

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.836
  Shapiro-Wilk p: 0.268


Outcome: PRP T2 Mean RT (Short SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0156, p = 0.330
  Step 2 (UCLA):        Delta R^2 = 0.0033, p = 0.421 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0110, p = 0.197 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 20.4050, SE = 25.2841, t = 0.81, p = 0.420

UCLA x Gender Interaction (Model 3):
  beta = 55.3916, SE = 42.7605, p = 0.195

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 18.2743, p = 0.560
  Male (n=82):   beta = 2.9968, p = 0.944

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.750
  Shapiro-Wilk p: 0.007


Outcome: PRP T2 Mean RT (Long SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0266, p = 0.137
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.930 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0026, p = 0.552 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.5396, SE = 17.6126, t = -0.09, p = 0.930

UCLA x Gender Interaction (Model 3):
  beta = 18.8242, SE = 31.5934, p = 0.551

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 1.6449, p = 0.942
  Male (n=82):   beta = -15.8635, p = 0.606

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.732
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 RT SD (Short SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0027, p = 0.909
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.680 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0009, p = 0.698 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.0650, SE = 9.8424, t = 0.41, p = 0.680

UCLA x Gender Interaction (Model 3):
  beta = 6.3223, SE = 16.2721, p = 0.698

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 5.3076, p = 0.677
  Male (n=82):   beta = -1.6369, p = 0.916

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.252
  Shapiro-Wilk p: 0.140


Outcome: PRP T2 RT SD (Long SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0059, p = 0.747
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.800 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0011, p = 0.641 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.8705, SE = 11.2953, t = -0.25, p = 0.799

UCLA x Gender Interaction (Model 3):
  beta = 8.2074, SE = 17.5830, p = 0.641

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -1.0861, p = 0.943
  Male (n=82):   beta = -11.6893, p = 0.497

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.801
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Coefficient of Variation (All) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0314, p = 0.094
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.830 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.902 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0013, SE = 0.0062, t = 0.21, p = 0.830

UCLA x Gender Interaction (Model 3):
  beta = -0.0012, SE = 0.0094, p = 0.902

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0023, p = 0.772
  Male (n=82):   beta = 0.0089, p = 0.443

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.702
  Shapiro-Wilk p: 0.158


Outcome: PRP T2 CV (Short SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0179, p = 0.303
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.789 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0043, p = 0.388 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0021, SE = 0.0077, t = -0.27, p = 0.789

UCLA x Gender Interaction (Model 3):
  beta = -0.0096, SE = 0.0111, p = 0.387

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0011, p = 0.904
  Male (n=82):   beta = -0.0009, p = 0.947

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.098
  Shapiro-Wilk p: 0.039


Outcome: PRP T2 CV (Long SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0032, p = 0.886
  Step 2 (UCLA):        Delta R^2 = 0.0023, p = 0.488 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.488 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0077, SE = 0.0111, t = -0.70, p = 0.487

UCLA x Gender Interaction (Model 3):
  beta = 0.0124, SE = 0.0179, p = 0.487

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0095, p = 0.525
  Male (n=82):   beta = -0.0073, p = 0.663

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.841
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Rate (N = 147)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0080, p = 0.767
  Step 2 (UCLA):        Delta R^2 = 0.0026, p = 0.508 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0117, p = 0.157 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0098, SE = 0.0147, t = 0.66, p = 0.507

UCLA x Gender Interaction (Model 3):
  beta = 0.0304, SE = 0.0214, p = 0.155

Gender-Stratified UCLA Effects:
  Female (n=97): beta = 0.0003, p = 0.985
  Male (n=50):   beta = 0.0267, p = 0.356

Diagnostics:
  VIF max: 2.93
  Breusch-Pagan p: 0.920
  Shapiro-Wilk p: < 0.001


Outcome: PRP Cascade Inflation (N = 133)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0067, p = 0.834
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.952 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0122, p = 0.095 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0253, SE = 0.4216, t = -0.06, p = 0.952

UCLA x Gender Interaction (Model 3):
  beta = 1.1256, SE = 0.6698, p = 0.093

Gender-Stratified UCLA Effects:
  Female (n=88): beta = -0.3095, p = 0.597
  Male (n=45):   beta = 0.4942, p = 0.467

Diagnostics:
  VIF max: 2.97
  Breusch-Pagan p: 0.926
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error Slowing (ms) (N = 170)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0077, p = 0.722
  Step 2 (UCLA):        Delta R^2 = 0.0043, p = 0.346 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0045, p = 0.368 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 36.2557, SE = 38.3437, t = 0.95, p = 0.344

UCLA x Gender Interaction (Model 3):
  beta = 53.1743, SE = 58.8929, p = 0.367

Gender-Stratified UCLA Effects:
  Female (n=103): beta = 35.9140, p = 0.477
  Male (n=67):   beta = -3.5505, p = 0.945

Diagnostics:
  VIF max: 2.82
  Breusch-Pagan p: 0.914
  Shapiro-Wilk p: < 0.001


Outcome: PRP Valid T2 Trial Count (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0300, p = 0.106
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.911 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0009, p = 0.687 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0901, SE = 0.8098, t = 0.11, p = 0.911

UCLA x Gender Interaction (Model 3):
  beta = -0.4983, SE = 1.2346, p = 0.686

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.1719, p = 0.866
  Male (n=82):   beta = 0.0835, p = 0.955

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.361
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (Short SOA) (N = 204)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0230, p = 0.176
  Step 2 (UCLA):        Delta R^2 = 0.0087, p = 0.232 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0101, p = 0.269 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 37.5546, SE = 31.3160, t = 1.20, p = 0.230

UCLA x Gender Interaction (Model 3):
  beta = 60.0999, SE = 54.2338, p = 0.268

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 30.4043, p = 0.438
  Male (n=82):   beta = 26.7050, p = 0.620

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.648
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Short SOA) (N = 204)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0206, p = 0.230
  Step 2 (UCLA):        Delta R^2 = 0.0213, p = 0.059 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0121, p = 0.173 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 22.2200, SE = 11.6986, t = 1.90, p = 0.058

UCLA x Gender Interaction (Model 3):
  beta = 24.9528, SE = 18.2555, p = 0.172

Gender-Stratified UCLA Effects:
  Female (n=122): beta = 14.2812, p = 0.359
  Male (n=82):   beta = 27.4945, p = 0.095

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.624
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (Short SOA) (N = 204)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0221, p = 0.217
  Step 2 (UCLA):        Delta R^2 = 0.0054, p = 0.324 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.798 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -16.7645, SE = 16.9556, t = -0.99, p = 0.323

UCLA x Gender Interaction (Model 3):
  beta = -6.8006, SE = 26.5109, p = 0.798

Gender-Stratified UCLA Effects:
  Female (n=122): beta = -11.4370, p = 0.602
  Male (n=82):   beta = -23.7119, p = 0.397

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.285
  Shapiro-Wilk p: 0.374


Outcome: PRP Ex-Gaussian mu (Long SOA) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0357, p = 0.072
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.938 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0045, p = 0.413 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.9899, SE = 12.7102, t = 0.08, p = 0.938

UCLA x Gender Interaction (Model 3):
  beta = 18.1277, SE = 22.1003, p = 0.412

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -2.0273, p = 0.904
  Male (n=80):   beta = -0.1772, p = 0.993

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.731
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Long SOA) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0382, p = 0.058
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.628 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.705 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 2.6721, SE = 5.4980, t = 0.49, p = 0.627

UCLA x Gender Interaction (Model 3):
  beta = 3.3020, SE = 8.6978, p = 0.704

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.2669, p = 0.865
  Male (n=80):   beta = 7.8906, p = 0.371

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.807
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (Long SOA) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0166, p = 0.354
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.749 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.707 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.1751, SE = 13.0406, t = -0.32, p = 0.749

UCLA x Gender Interaction (Model 3):
  beta = 7.8187, SE = 20.7414, p = 0.706

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.7461, p = 0.919
  Male (n=80):   beta = -14.2027, p = 0.505

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.682
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (Overall) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0320, p = 0.077
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.897 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0018, p = 0.631 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.6209, SE = 27.9037, t = -0.13, p = 0.897

UCLA x Gender Interaction (Model 3):
  beta = 22.9860, SE = 47.8274, p = 0.631

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 4.4276, p = 0.893
  Male (n=82):   beta = -28.9757, p = 0.618

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.392
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Overall) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0198, p = 0.233
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.962 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.664 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.6893, SE = 14.4534, t = 0.05, p = 0.962

UCLA x Gender Interaction (Model 3):
  beta = 10.6966, SE = 24.5698, p = 0.663

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 3.2939, p = 0.854
  Male (n=82):   beta = -9.9944, p = 0.720

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.258
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (Overall) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0172, p = 0.325
  Step 2 (UCLA):        Delta R^2 = 0.0027, p = 0.471 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0026, p = 0.518 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 10.4810, SE = 14.5006, t = 0.72, p = 0.470

UCLA x Gender Interaction (Model 3):
  beta = 15.2834, SE = 23.6123, p = 0.517

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 4.3440, p = 0.800
  Male (n=82):   beta = 16.8111, p = 0.562

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.761
  Shapiro-Wilk p: 0.213


Outcome: PRP Ex-Gaussian mu (Bottleneck) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0334, p = 0.072
  Step 2 (UCLA):        Delta R^2 = 0.0067, p = 0.283 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0126, p = 0.210 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 27.9678, SE = 25.9510, t = 1.08, p = 0.281

UCLA x Gender Interaction (Model 3):
  beta = 57.2826, SE = 45.5637, p = 0.209

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 14.5130, p = 0.641
  Male (n=80):   beta = 25.2956, p = 0.581

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.464
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Bottleneck) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0529, p = 0.014
  Step 2 (UCLA):        Delta R^2 = 0.0151, p = 0.087 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0105, p = 0.195 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.3673, SE = 11.2402, t = 1.72, p = 0.085

UCLA x Gender Interaction (Model 3):
  beta = 24.3046, SE = 18.6864, p = 0.193

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 13.6275, p = 0.349
  Male (n=80):   beta = 19.2540, p = 0.302

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.885
  Shapiro-Wilk p: 0.005


Outcome: PRP Ex-Gaussian tau (Bottleneck) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0393, p = 0.053
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.714 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0023, p = 0.583 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -6.9329, SE = 18.9198, t = -0.37, p = 0.714

UCLA x Gender Interaction (Model 3):
  beta = -17.6631, SE = 32.1009, p = 0.582

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -1.3516, p = 0.952
  Male (n=80):   beta = -7.4164, p = 0.838

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.569
  Shapiro-Wilk p: 0.012


Outcome: PRP CB Base RT (ms) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0233, p = 0.188
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.786 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0010, p = 0.714 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.8693, SE = 17.9087, t = -0.27, p = 0.786

UCLA x Gender Interaction (Model 3):
  beta = 11.8334, SE = 32.2196, p = 0.713

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 1.8967, p = 0.935
  Male (n=82):   beta = -24.3924, p = 0.436

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.791
  Shapiro-Wilk p: < 0.001


Outcome: PRP CB Bottleneck Duration (ms) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0022, p = 0.924
  Step 2 (UCLA):        Delta R^2 = 0.0067, p = 0.272 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0153, p = 0.105 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.6337, SE = 17.8247, t = 1.10, p = 0.271

UCLA x Gender Interaction (Model 3):
  beta = 43.8488, SE = 26.9633, p = 0.104

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 10.5482, p = 0.639
  Male (n=82):   beta = 24.1281, p = 0.403

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.718
  Shapiro-Wilk p: 0.196


Outcome: PRP CB Model R-squared (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0151, p = 0.372
  Step 2 (UCLA):        Delta R^2 = 0.0283, p = 0.026 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0112, p = 0.222 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0392, SE = 0.0175, t = 2.24, p = 0.025

UCLA x Gender Interaction (Model 3):
  beta = 0.0367, SE = 0.0299, p = 0.221

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0256, p = 0.177
  Male (n=82):   beta = 0.0549, p = 0.103

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.112
  Shapiro-Wilk p: < 0.001


Outcome: PRP CB Slope (short SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0226, p = 0.207
  Step 2 (UCLA):        Delta R^2 = 0.0196, p = 0.043 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0048, p = 0.320 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0981, SE = 0.0481, t = -2.04, p = 0.042

UCLA x Gender Interaction (Model 3):
  beta = -0.0718, SE = 0.0721, p = 0.319

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0798, p = 0.147
  Male (n=82):   beta = -0.1099, p = 0.244

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.392
  Shapiro-Wilk p: 0.082


Outcome: PRP Slow-State Probability (Baseline) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0220, p = 0.215
  Step 2 (UCLA):        Delta R^2 = 0.0092, p = 0.186 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.895 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0284, SE = 0.0214, t = 1.33, p = 0.185

UCLA x Gender Interaction (Model 3):
  beta = 0.0043, SE = 0.0324, p = 0.895

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0334, p = 0.227
  Male (n=82):   beta = 0.0199, p = 0.580

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.194
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow-State Prob (Post-Error) (N = 183)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0089, p = 0.657
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.714 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0023, p = 0.524 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0119, SE = 0.0323, t = 0.37, p = 0.713

UCLA x Gender Interaction (Model 3):
  beta = 0.0298, SE = 0.0466, p = 0.523

Gender-Stratified UCLA Effects:
  Female (n=112): beta = 0.0081, p = 0.837
  Male (n=71):   beta = 0.0154, p = 0.777

Diagnostics:
  VIF max: 2.79
  Breusch-Pagan p: 0.830
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow-State Prob Delta (Post-Error) (N = 183)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0085, p = 0.678
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.458 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.731 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0152, SE = 0.0205, t = -0.74, p = 0.457

UCLA x Gender Interaction (Model 3):
  beta = 0.0111, SE = 0.0323, p = 0.730

Gender-Stratified UCLA Effects:
  Female (n=112): beta = -0.0184, p = 0.471
  Male (n=71):   beta = -0.0163, p = 0.654

Diagnostics:
  VIF max: 2.79
  Breusch-Pagan p: 0.658
  Shapiro-Wilk p: 0.876


Outcome: PRP Slow-State Prob (Stable) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0196, p = 0.264
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.238 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.973 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0258, SE = 0.0218, t = 1.18, p = 0.237

UCLA x Gender Interaction (Model 3):
  beta = -0.0011, SE = 0.0335, p = 0.973

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0330, p = 0.244
  Male (n=82):   beta = 0.0149, p = 0.680

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.138
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow-State Prob Delta (Stable) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0068, p = 0.712
  Step 2 (UCLA):        Delta R^2 = 0.0040, p = 0.407 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0077, p = 0.156 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0026, SE = 0.0032, t = -0.83, p = 0.406

UCLA x Gender Interaction (Model 3):
  beta = -0.0054, SE = 0.0038, p = 0.155

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0005, p = 0.912
  Male (n=82):   beta = -0.0049, p = 0.232

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.659
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Cost (Short - Long) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0020, p = 0.941
  Step 2 (UCLA):        Delta R^2 = 0.0282, p = 0.008 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.787 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 55.6427, SE = 20.7052, t = 2.69, p = 0.007

UCLA x Gender Interaction (Model 3):
  beta = 9.2634, SE = 34.2374, p = 0.787

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 38.4045, p = 0.162
  Male (n=82):   beta = 84.3071, p = 0.015

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.639
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0010, p = 0.978
  Step 2 (UCLA):        Delta R^2 = 0.0075, p = 0.145 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.782 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0185, SE = 0.0126, t = 1.46, p = 0.143

UCLA x Gender Interaction (Model 3):
  beta = 0.0059, SE = 0.0213, p = 0.781

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0110, p = 0.476
  Male (n=82):   beta = 0.0317, p = 0.177

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.771
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 RT (T1 Error) (N = 147)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0513, p = 0.046
  Step 2 (UCLA):        Delta R^2 = 0.0052, p = 0.421 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0105, p = 0.192 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 55.7584, SE = 69.0244, t = 0.81, p = 0.419

UCLA x Gender Interaction (Model 3):
  beta = 117.0787, SE = 89.3410, p = 0.190

Gender-Stratified UCLA Effects:
  Female (n=97): beta = 45.1289, p = 0.631
  Male (n=50):   beta = 79.7870, p = 0.550

Diagnostics:
  VIF max: 2.93
  Breusch-Pagan p: 0.431
  Shapiro-Wilk p: 0.871


Outcome: PRP T2 RT (T1 Correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0211, p = 0.206
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.794 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0065, p = 0.326 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.9400, SE = 22.7019, t = 0.26, p = 0.794

UCLA x Gender Interaction (Model 3):
  beta = 37.8847, SE = 38.4353, p = 0.324

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 8.2079, p = 0.775
  Male (n=82):   beta = -13.5109, p = 0.731

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.877
  Shapiro-Wilk p: 0.003


Outcome: PRP T2 Interference (T1 Error - Correct) (N = 147)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0331, p = 0.175
  Step 2 (UCLA):        Delta R^2 = 0.0064, p = 0.432 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0042, p = 0.495 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 55.0215, SE = 69.8276, t = 0.79, p = 0.431

UCLA x Gender Interaction (Model 3):
  beta = 65.9470, SE = 96.4524, p = 0.494

Gender-Stratified UCLA Effects:
  Female (n=97): beta = 32.4877, p = 0.743
  Male (n=50):   beta = 128.7599, p = 0.340

Diagnostics:
  VIF max: 2.93
  Breusch-Pagan p: 0.573
  Shapiro-Wilk p: 0.430


Outcome: PRP T2 RT Slope (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0296, p = 0.110
  Step 2 (UCLA):        Delta R^2 = 0.0049, p = 0.306 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0088, p = 0.202 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.2383, SE = 0.2322, t = 1.03, p = 0.305

UCLA x Gender Interaction (Model 3):
  beta = -0.4745, SE = 0.3708, p = 0.201

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.3867, p = 0.210
  Male (n=82):   beta = 0.0851, p = 0.821

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.402
  Shapiro-Wilk p: 0.379


Outcome: PRP Order Violation Rate (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0123, p = 0.481
  Step 2 (UCLA):        Delta R^2 = 0.0014, p = 0.598 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.757 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0024, SE = 0.0046, t = -0.53, p = 0.597

UCLA x Gender Interaction (Model 3):
  beta = -0.0024, SE = 0.0076, p = 0.756

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0023, p = 0.683
  Male (n=82):   beta = -0.0012, p = 0.887

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.644
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1-only Rate (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0106, p = 0.536
  Step 2 (UCLA):        Delta R^2 = 0.0027, p = 0.516 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0028, p = 0.276 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0005, SE = 0.0008, t = 0.65, p = 0.516

UCLA x Gender Interaction (Model 3):
  beta = 0.0008, SE = 0.0008, p = 0.275

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0005, p = 0.661
  Male (n=82):   beta = 0.0001, p = 0.871

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.303
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2-only Rate (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0122, p = 0.482
  Step 2 (UCLA):        Delta R^2 = 0.0006, p = 0.661 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.933 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0003, SE = 0.0007, t = -0.44, p = 0.661

UCLA x Gender Interaction (Model 3):
  beta = 0.0001, SE = 0.0011, p = 0.933

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0000, p = 0.962
  Male (n=82):   beta = -0.0010, p = 0.328

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.784
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 While T1 Pending Rate (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0146, p = 0.399
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.578 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.765 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0026, SE = 0.0047, t = -0.56, p = 0.577

UCLA x Gender Interaction (Model 3):
  beta = -0.0023, SE = 0.0076, p = 0.764

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0024, p = 0.678
  Male (n=82):   beta = -0.0017, p = 0.847

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.639
  Shapiro-Wilk p: < 0.001


Outcome: PRP IRI Mean (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0039, p = 0.849
  Step 2 (UCLA):        Delta R^2 = 0.0095, p = 0.159 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0033, p = 0.446 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 22.9535, SE = 16.2421, t = 1.41, p = 0.158

UCLA x Gender Interaction (Model 3):
  beta = -20.0378, SE = 26.2485, p = 0.445

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 24.3573, p = 0.281
  Male (n=82):   beta = 23.9230, p = 0.386

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.736
  Shapiro-Wilk p: 0.001


Outcome: PRP IRI Median (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0065, p = 0.714
  Step 2 (UCLA):        Delta R^2 = 0.0103, p = 0.172 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0012, p = 0.630 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 24.4447, SE = 17.8460, t = 1.37, p = 0.171

UCLA x Gender Interaction (Model 3):
  beta = -12.5403, SE = 25.9664, p = 0.629

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 26.3607, p = 0.280
  Male (n=82):   beta = 22.0685, p = 0.463

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.307
  Shapiro-Wilk p: 0.033


Outcome: PRP IRI p10 (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0172, p = 0.296
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.924 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.702 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1466, SE = 12.0835, t = -0.09, p = 0.924

UCLA x Gender Interaction (Model 3):
  beta = 6.8626, SE = 17.9174, p = 0.702

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -2.6932, p = 0.875
  Male (n=82):   beta = -1.7945, p = 0.920

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.525
  Shapiro-Wilk p: 0.071


Outcome: PRP IRI p25 (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0133, p = 0.418
  Step 2 (UCLA):        Delta R^2 = 0.0017, p = 0.559 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.980 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 8.1502, SE = 13.9298, t = 0.59, p = 0.558

UCLA x Gender Interaction (Model 3):
  beta = -0.5245, SE = 20.9805, p = 0.980

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 7.5818, p = 0.693
  Male (n=82):   beta = 7.8534, p = 0.732

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.093
  Shapiro-Wilk p: 0.054


Outcome: PRP T1 Error Run Mean (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0224, p = 0.187
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.749 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.837 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0164, SE = 0.0512, t = 0.32, p = 0.748

UCLA x Gender Interaction (Model 3):
  beta = -0.0177, SE = 0.0859, p = 0.837

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0289, p = 0.670
  Male (n=82):   beta = -0.0182, p = 0.838

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.388
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Error Run Max (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0186, p = 0.264
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.940 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.726 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0057, SE = 0.0756, t = 0.08, p = 0.940

UCLA x Gender Interaction (Model 3):
  beta = 0.0399, SE = 0.1136, p = 0.726

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0010, p = 0.993
  Male (n=82):   beta = -0.0130, p = 0.903

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.680
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Error Run Mean (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0488, p = 0.018
  Step 2 (UCLA):        Delta R^2 = 0.0030, p = 0.502 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.917 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0324, SE = 0.0481, t = -0.67, p = 0.501

UCLA x Gender Interaction (Model 3):
  beta = -0.0065, SE = 0.0618, p = 0.917

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0098, p = 0.877
  Male (n=82):   beta = -0.0811, p = 0.327

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.404
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Error Run Max (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0320, p = 0.090
  Step 2 (UCLA):        Delta R^2 = 0.0065, p = 0.327 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.714 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0711, SE = 0.0724, t = -0.98, p = 0.326

UCLA x Gender Interaction (Model 3):
  beta = 0.0344, SE = 0.0939, p = 0.714

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0639, p = 0.502
  Male (n=82):   beta = -0.0986, p = 0.396

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.746
  Shapiro-Wilk p: < 0.001


Outcome: PRP Cascade Run Mean (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0093, p = 0.601
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.470 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0200, p = 0.075 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0275, SE = 0.0380, t = 0.72, p = 0.469

UCLA x Gender Interaction (Model 3):
  beta = 0.1039, SE = 0.0580, p = 0.073

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0006, p = 0.990
  Male (n=82):   beta = 0.0554, p = 0.415

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.328
  Shapiro-Wilk p: < 0.001


Outcome: PRP Cascade Run Max (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0093, p = 0.601
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.470 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0200, p = 0.075 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0275, SE = 0.0380, t = 0.72, p = 0.469

UCLA x Gender Interaction (Model 3):
  beta = 0.1039, SE = 0.0580, p = 0.073

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0006, p = 0.990
  Male (n=82):   beta = 0.0554, p = 0.415

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.328
  Shapiro-Wilk p: < 0.001


Outcome: PRP DFA Alpha (Short SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0126, p = 0.461
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.925 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0026, p = 0.545 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0020, SE = 0.0217, t = 0.09, p = 0.925

UCLA x Gender Interaction (Model 3):
  beta = -0.0218, SE = 0.0360, p = 0.545

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0107, p = 0.713
  Male (n=82):   beta = -0.0168, p = 0.630

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.535
  Shapiro-Wilk p: 0.005


Outcome: PRP DFA Alpha (Long SOA, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0291, p = 0.133
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.427 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0044, p = 0.327 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0903, SE = 0.1134, t = -0.80, p = 0.426

UCLA x Gender Interaction (Model 3):
  beta = 0.1596, SE = 0.1622, p = 0.325

Gender-Stratified UCLA Effects:
  Female (n=113): beta = -0.1099, p = 0.484
  Male (n=80):   beta = -0.0724, p = 0.664

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.308
  Shapiro-Wilk p: < 0.001


Outcome: PRP Lag-1 Autocorr (Short SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0060, p = 0.750
  Step 2 (UCLA):        Delta R^2 = 0.0045, p = 0.391 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0054, p = 0.389 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0159, SE = 0.0185, t = -0.86, p = 0.390

UCLA x Gender Interaction (Model 3):
  beta = -0.0259, SE = 0.0300, p = 0.388

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0089, p = 0.735
  Male (n=82):   beta = -0.0266, p = 0.302

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.387
  Shapiro-Wilk p: 0.545


Outcome: PRP Lag-1 Autocorr (Long SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0027, p = 0.909
  Step 2 (UCLA):        Delta R^2 = 0.0018, p = 0.570 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0042, p = 0.399 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0130, SE = 0.0229, t = 0.57, p = 0.569

UCLA x Gender Interaction (Model 3):
  beta = -0.0293, SE = 0.0347, p = 0.398

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0419, p = 0.134
  Male (n=82):   beta = -0.0390, p = 0.288

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.387
  Shapiro-Wilk p: 0.009


Outcome: PRP Slow Run Mean (Short SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0098, p = 0.576
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.860 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0043, p = 0.374 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0077, SE = 0.0434, t = -0.18, p = 0.860

UCLA x Gender Interaction (Model 3):
  beta = -0.0567, SE = 0.0636, p = 0.373

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0167, p = 0.775
  Male (n=82):   beta = -0.0600, p = 0.407

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.463
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow Run Max (Short SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0060, p = 0.753
  Step 2 (UCLA):        Delta R^2 = 0.0037, p = 0.395 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0069, p = 0.299 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1610, SE = 0.1888, t = 0.85, p = 0.394

UCLA x Gender Interaction (Model 3):
  beta = -0.3271, SE = 0.3139, p = 0.297

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.3742, p = 0.114
  Male (n=82):   beta = -0.2221, p = 0.490

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.407
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Mean (Short SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0101, p = 0.564
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.683 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0016, p = 0.569 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0186, SE = 0.0454, t = 0.41, p = 0.682

UCLA x Gender Interaction (Model 3):
  beta = -0.0361, SE = 0.0633, p = 0.568

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0353, p = 0.572
  Male (n=82):   beta = -0.0246, p = 0.728

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.425
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Max (Short SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0057, p = 0.765
  Step 2 (UCLA):        Delta R^2 = 0.0012, p = 0.678 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.775 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0814, SE = 0.1959, t = -0.42, p = 0.678

UCLA x Gender Interaction (Model 3):
  beta = -0.0723, SE = 0.2525, p = 0.775

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0242, p = 0.927
  Male (n=82):   beta = -0.3543, p = 0.266

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.621
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow Run Mean (Long SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0172, p = 0.324
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.866 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0054, p = 0.260 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0097, SE = 0.0572, t = 0.17, p = 0.866

UCLA x Gender Interaction (Model 3):
  beta = 0.0885, SE = 0.0783, p = 0.258

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0332, p = 0.655
  Male (n=82):   beta = -0.0681, p = 0.555

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.317
  Shapiro-Wilk p: < 0.001


Outcome: PRP Slow Run Max (Long SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0214, p = 0.229
  Step 2 (UCLA):        Delta R^2 = 0.0023, p = 0.510 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0057, p = 0.280 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1005, SE = 0.1522, t = 0.66, p = 0.509

UCLA x Gender Interaction (Model 3):
  beta = 0.2345, SE = 0.2165, p = 0.279

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0951, p = 0.601
  Male (n=82):   beta = 0.0737, p = 0.806

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.239
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Mean (Long SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0061, p = 0.747
  Step 2 (UCLA):        Delta R^2 = 0.0006, p = 0.655 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0055, p = 0.218 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0251, SE = 0.0561, t = 0.45, p = 0.655

UCLA x Gender Interaction (Model 3):
  beta = 0.1083, SE = 0.0877, p = 0.217

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0500, p = 0.475
  Male (n=82):   beta = -0.0605, p = 0.615

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.987
  Shapiro-Wilk p: < 0.001


Outcome: PRP Fast Run Max (Long SOA, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0206, p = 0.239
  Step 2 (UCLA):        Delta R^2 = 0.0022, p = 0.497 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0032, p = 0.480 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0946, SE = 0.1390, t = 0.68, p = 0.496

UCLA x Gender Interaction (Model 3):
  beta = 0.1692, SE = 0.2393, p = 0.479

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.1766, p = 0.293
  Male (n=82):   beta = -0.0960, p = 0.712

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.286
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (Bottleneck, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0319, p = 0.084
  Step 2 (UCLA):        Delta R^2 = 0.0057, p = 0.327 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0097, p = 0.277 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 25.9970, SE = 26.4293, t = 0.98, p = 0.325

UCLA x Gender Interaction (Model 3):
  beta = 50.5719, SE = 46.3539, p = 0.275

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 19.6859, p = 0.537
  Male (n=80):   beta = 14.6863, p = 0.758

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.554
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (Bottleneck, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0495, p = 0.020
  Step 2 (UCLA):        Delta R^2 = 0.0086, p = 0.201 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0062, p = 0.323 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 14.9999, SE = 11.6921, t = 1.28, p = 0.200

UCLA x Gender Interaction (Model 3):
  beta = 18.9839, SE = 19.1629, p = 0.322

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 13.5404, p = 0.384
  Male (n=80):   beta = 9.1714, p = 0.634

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.818
  Shapiro-Wilk p: 0.004


Outcome: PRP Ex-Gaussian tau (Bottleneck, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0331, p = 0.092
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.980 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0011, p = 0.707 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.4867, SE = 19.4257, t = 0.03, p = 0.980

UCLA x Gender Interaction (Model 3):
  beta = -12.5913, SE = 33.4621, p = 0.707

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 1.2504, p = 0.957
  Male (n=80):   beta = 4.9901, p = 0.896

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.852
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau Ratio (Short/Long) (N = 195)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0253, p = 0.174
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.958 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.687 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0343, SE = 0.6517, t = 0.05, p = 0.958

UCLA x Gender Interaction (Model 3):
  beta = -0.3211, SE = 0.7965, p = 0.687

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 0.6422, p = 0.321
  Male (n=80):   beta = -0.9522, p = 0.520

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.347
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau Ratio (Short/Long, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0277, p = 0.142
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.906 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.919 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0682, SE = 0.5791, t = -0.12, p = 0.906

UCLA x Gender Interaction (Model 3):
  beta = -0.0783, SE = 0.7709, p = 0.919

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 0.3544, p = 0.444
  Male (n=80):   beta = -0.7120, p = 0.628

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.250
  Shapiro-Wilk p: < 0.001


Outcome: PRP Bottleneck AUC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0223, p = 0.188
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.934 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0050, p = 0.382 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 2097.9736, SE = 25342.6437, t = 0.08, p = 0.934

UCLA x Gender Interaction (Model 3):
  beta = 37043.4419, SE = 42266.3980, p = 0.381

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 5981.2603, p = 0.852
  Male (n=82):   beta = -20212.4763, p = 0.650

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.955
  Shapiro-Wilk p: 0.001


Outcome: PRP Bottleneck Slope (Short Range) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0226, p = 0.207
  Step 2 (UCLA):        Delta R^2 = 0.0196, p = 0.043 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0048, p = 0.320 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0981, SE = 0.0481, t = -2.04, p = 0.042

UCLA x Gender Interaction (Model 3):
  beta = -0.0718, SE = 0.0721, p = 0.319

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0798, p = 0.147
  Male (n=82):   beta = -0.1099, p = 0.244

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.392
  Shapiro-Wilk p: 0.082


Outcome: PRP Bottleneck Slope (Long Range) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0077, p = 0.637
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.947 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0044, p = 0.382 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0012, SE = 0.0183, t = 0.07, p = 0.947

UCLA x Gender Interaction (Model 3):
  beta = -0.0243, SE = 0.0278, p = 0.381

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0012, p = 0.955
  Male (n=82):   beta = 0.0095, p = 0.781

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.989
  Shapiro-Wilk p: 0.219


Outcome: PRP RT2 Asymptote (Long SOA) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0260, p = 0.145
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.915 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.547 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.8912, SE = 17.6051, t = -0.11, p = 0.914

UCLA x Gender Interaction (Model 3):
  beta = 19.0222, SE = 31.5566, p = 0.547

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 1.2471, p = 0.956
  Male (n=82):   beta = -15.9561, p = 0.606

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.745
  Shapiro-Wilk p: < 0.001


Outcome: PRP Bottleneck Curvature (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0431, p = 0.031
  Step 2 (UCLA):        Delta R^2 = 0.0116, p = 0.144 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0037, p = 0.420 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0000, SE = 0.0000, t = 1.47, p = 0.142

UCLA x Gender Interaction (Model 3):
  beta = 0.0000, SE = 0.0000, p = 0.419

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0000, p = 0.441
  Male (n=82):   beta = 0.0001, p = 0.280

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.375
  Shapiro-Wilk p: 0.003


Outcome: PRP CB AIC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0084, p = 0.630
  Step 2 (UCLA):        Delta R^2 = 0.0096, p = 0.202 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.876 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.8209, SE = 0.6413, t = -1.28, p = 0.201

UCLA x Gender Interaction (Model 3):
  beta = -0.1294, SE = 0.8268, p = 0.876

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.5872, p = 0.479
  Male (n=82):   beta = -1.3830, p = 0.187

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.957
  Shapiro-Wilk p: < 0.001


Outcome: PRP CB BIC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0084, p = 0.630
  Step 2 (UCLA):        Delta R^2 = 0.0096, p = 0.202 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.876 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.8209, SE = 0.6413, t = -1.28, p = 0.201

UCLA x Gender Interaction (Model 3):
  beta = -0.1294, SE = 0.8268, p = 0.876

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.5872, p = 0.479
  Male (n=82):   beta = -1.3830, p = 0.187

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.957
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS Base RT (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0310, p = 0.089
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.627 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.894 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 10.4091, SE = 21.4143, t = 0.49, p = 0.627

UCLA x Gender Interaction (Model 3):
  beta = -4.8786, SE = 36.4058, p = 0.893

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 19.1676, p = 0.449
  Male (n=82):   beta = -4.5555, p = 0.910

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.272
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS Amplitude (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0069, p = 0.665
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.725 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0119, p = 0.130 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 11.3431, SE = 32.2386, t = 0.35, p = 0.725

UCLA x Gender Interaction (Model 3):
  beta = 70.0701, SE = 46.1258, p = 0.129

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -4.9432, p = 0.896
  Male (n=82):   beta = 17.3211, p = 0.760

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.563
  Shapiro-Wilk p: 0.005


Outcome: PRP CS Tau (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0259, p = 0.145
  Step 2 (UCLA):        Delta R^2 = 0.0125, p = 0.126 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.916 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -86.3188, SE = 56.2394, t = -1.53, p = 0.125

UCLA x Gender Interaction (Model 3):
  beta = 9.7188, SE = 92.1550, p = 0.916

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -82.4608, p = 0.237
  Male (n=82):   beta = -99.0419, p = 0.352

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.418
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS R-squared (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0107, p = 0.532
  Step 2 (UCLA):        Delta R^2 = 0.0163, p = 0.098 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0060, p = 0.326 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0127, SE = 0.0076, t = 1.66, p = 0.096

UCLA x Gender Interaction (Model 3):
  beta = 0.0115, SE = 0.0117, p = 0.325

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0109, p = 0.077
  Male (n=82):   beta = 0.0130, p = 0.457

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.161
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS RMSE (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0088, p = 0.619
  Step 2 (UCLA):        Delta R^2 = 0.0121, p = 0.120 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.943 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.4246, SE = 2.8355, t = -1.56, p = 0.119

UCLA x Gender Interaction (Model 3):
  beta = -0.3032, SE = 4.2619, p = 0.943

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -4.9039, p = 0.114
  Male (n=82):   beta = -3.6716, p = 0.513

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.156
  Shapiro-Wilk p: < 0.001


Outcome: PRP CS AIC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0056, p = 0.769
  Step 2 (UCLA):        Delta R^2 = 0.0172, p = 0.096 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0017, p = 0.550 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1199, SE = 0.6696, t = -1.67, p = 0.094

UCLA x Gender Interaction (Model 3):
  beta = 0.5286, SE = 0.8834, p = 0.550

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -1.6280, p = 0.058
  Male (n=82):   beta = -0.3557, p = 0.744

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.149
  Shapiro-Wilk p: 0.008


Outcome: PRP CS BIC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0056, p = 0.769
  Step 2 (UCLA):        Delta R^2 = 0.0172, p = 0.096 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0017, p = 0.550 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1199, SE = 0.6696, t = -1.67, p = 0.094

UCLA x Gender Interaction (Model 3):
  beta = 0.5286, SE = 0.8834, p = 0.550

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -1.6280, p = 0.058
  Male (n=82):   beta = -0.3557, p = 0.744

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.149
  Shapiro-Wilk p: 0.008


Outcome: PRP Mix CB Weight (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0114, p = 0.503
  Step 2 (UCLA):        Delta R^2 = 0.0014, p = 0.598 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.363 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0197, SE = 0.0373, t = 0.53, p = 0.598

UCLA x Gender Interaction (Model 3):
  beta = 0.0484, SE = 0.0531, p = 0.362

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0116, p = 0.817
  Male (n=82):   beta = 0.0735, p = 0.213

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.332
  Shapiro-Wilk p: < 0.001


Outcome: PRP Mix R-squared (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0108, p = 0.531
  Step 2 (UCLA):        Delta R^2 = 0.0185, p = 0.067 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0083, p = 0.244 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0134, SE = 0.0073, t = 1.84, p = 0.065

UCLA x Gender Interaction (Model 3):
  beta = 0.0133, SE = 0.0114, p = 0.242

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0099, p = 0.117
  Male (n=82):   beta = 0.0166, p = 0.309

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.072
  Shapiro-Wilk p: < 0.001


Outcome: PRP Mix RMSE (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0083, p = 0.638
  Step 2 (UCLA):        Delta R^2 = 0.0115, p = 0.135 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.807 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.4201, SE = 2.9415, t = -1.50, p = 0.133

UCLA x Gender Interaction (Model 3):
  beta = -1.0603, SE = 4.3288, p = 0.806

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -4.0807, p = 0.215
  Male (n=82):   beta = -5.2144, p = 0.362

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.142
  Shapiro-Wilk p: < 0.001


Outcome: PRP Mix AIC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0059, p = 0.756
  Step 2 (UCLA):        Delta R^2 = 0.0136, p = 0.143 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0010, p = 0.652 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1118, SE = 0.7554, t = -1.47, p = 0.141

UCLA x Gender Interaction (Model 3):
  beta = 0.4433, SE = 0.9822, p = 0.652

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -1.3952, p = 0.147
  Male (n=82):   beta = -0.8470, p = 0.499

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.206
  Shapiro-Wilk p: 0.010


Outcome: PRP Mix BIC (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0059, p = 0.756
  Step 2 (UCLA):        Delta R^2 = 0.0136, p = 0.143 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0010, p = 0.652 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.1118, SE = 0.7554, t = -1.47, p = 0.141

UCLA x Gender Interaction (Model 3):
  beta = 0.4433, SE = 0.9822, p = 0.652

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -1.3952, p = 0.147
  Male (n=82):   beta = -0.8470, p = 0.499

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.206
  Shapiro-Wilk p: 0.010


Outcome: PRP RT Fatigue Slope (Q4-Q1) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0305, p = 0.102
  Step 2 (UCLA):        Delta R^2 = 0.0022, p = 0.468 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0161, p = 0.094 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 14.5402, SE = 19.9867, t = 0.73, p = 0.467

UCLA x Gender Interaction (Model 3):
  beta = -58.1537, SE = 34.5344, p = 0.092

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 35.3850, p = 0.180
  Male (n=82):   beta = -11.6224, p = 0.724

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.244
  Shapiro-Wilk p: 0.031


Outcome: PRP CV Fatigue Slope (Q4-Q1) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0146, p = 0.389
  Step 2 (UCLA):        Delta R^2 = 0.0085, p = 0.170 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0412, p = 0.003 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0111, SE = 0.0081, t = -1.38, p = 0.168

UCLA x Gender Interaction (Model 3):
  beta = 0.0363, SE = 0.0121, p = 0.003

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0277, p = 0.003
  Male (n=82):   beta = 0.0116, p = 0.394

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.788
  Shapiro-Wilk p: 0.723


Outcome: PRP Accuracy Fatigue Slope (Q4-Q1) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0148, p = 0.395
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.820 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0011, p = 0.690 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0011, SE = 0.0047, t = -0.23, p = 0.820

UCLA x Gender Interaction (Model 3):
  beta = -0.0029, SE = 0.0073, p = 0.689

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0017, p = 0.766
  Male (n=82):   beta = -0.0071, p = 0.391

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.716
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Count (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0193, p = 0.274
  Step 2 (UCLA):        Delta R^2 = 0.0051, p = 0.331 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0042, p = 0.344 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0469, SE = 0.0481, t = -0.97, p = 0.330

UCLA x Gender Interaction (Model 3):
  beta = 0.0628, SE = 0.0662, p = 0.343

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0711, p = 0.262
  Male (n=82):   beta = -0.0139, p = 0.849

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.665
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Rate (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0195, p = 0.269
  Step 2 (UCLA):        Delta R^2 = 0.0050, p = 0.337 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0040, p = 0.354 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0393, SE = 0.0408, t = -0.96, p = 0.335

UCLA x Gender Interaction (Model 3):
  beta = 0.0520, SE = 0.0560, p = 0.353

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0599, p = 0.264
  Male (n=82):   beta = -0.0110, p = 0.862

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.661
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Mean Length (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0238, p = 0.184
  Step 2 (UCLA):        Delta R^2 = 0.0061, p = 0.315 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.617 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0796, SE = 0.0791, t = -1.01, p = 0.314

UCLA x Gender Interaction (Model 3):
  beta = 0.0567, SE = 0.1132, p = 0.616

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.1057, p = 0.250
  Male (n=82):   beta = -0.0457, p = 0.752

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.724
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Max Length (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0240, p = 0.182
  Step 2 (UCLA):        Delta R^2 = 0.0084, p = 0.258 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0024, p = 0.518 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0994, SE = 0.0876, t = -1.13, p = 0.257

UCLA x Gender Interaction (Model 3):
  beta = 0.0784, SE = 0.1209, p = 0.517

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.1369, p = 0.213
  Male (n=82):   beta = -0.0457, p = 0.752

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.621
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Trials (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0188, p = 0.284
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.278 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0047, p = 0.327 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.1263, SE = 0.1162, t = -1.09, p = 0.277

UCLA x Gender Interaction (Model 3):
  beta = 0.1494, SE = 0.1519, p = 0.325

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.1890, p = 0.248
  Male (n=82):   beta = -0.0337, p = 0.818

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.516
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Cascade Proportion (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0191, p = 0.278
  Step 2 (UCLA):        Delta R^2 = 0.0072, p = 0.282 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0045, p = 0.335 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.1058, SE = 0.0980, t = -1.08, p = 0.280

UCLA x Gender Interaction (Model 3):
  beta = 0.1238, SE = 0.1281, p = 0.334

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.1588, p = 0.247
  Male (n=82):   beta = -0.0268, p = 0.831

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.510
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery RT Slope (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0150, p = 0.710
  Step 2 (UCLA):        Delta R^2 = 0.0034, p = 0.576 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0332, p = 0.086 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -6.3537, SE = 11.3133, t = -0.56, p = 0.574

UCLA x Gender Interaction (Model 3):
  beta = 29.3658, SE = 16.9198, p = 0.083

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -18.0684, p = 0.240
  Male (n=39):   beta = 19.0392, p = 0.154

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.740
  Shapiro-Wilk p: 0.165


Outcome: PRP Recovery Accuracy Slope (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0160, p = 0.691
  Step 2 (UCLA):        Delta R^2 = 0.0339, p = 0.123 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0057, p = 0.541 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0076, SE = 0.0049, t = -1.56, p = 0.119

UCLA x Gender Interaction (Model 3):
  beta = 0.0046, SE = 0.0076, p = 0.540

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -0.0100, p = 0.103
  Male (n=39):   beta = -0.0049, p = 0.607

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.597
  Shapiro-Wilk p: < 0.001


Outcome: PRP Momentum Slope (N = 53)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0566, p = 0.424
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.868 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0251, p = 0.477 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.3178, SE = 13.8527, t = -0.17, p = 0.867

UCLA x Gender Interaction (Model 3):
  beta = 21.0178, SE = 29.2993, p = 0.473

Gender-Stratified UCLA Effects:
  Female (n=32): beta = -16.9898, p = 0.387
  Male (n=21):   beta = 21.4362, p = 0.188

Diagnostics:
  VIF max: 1.98
  Breusch-Pagan p: 0.309
  Shapiro-Wilk p: 0.890


Outcome: PRP Momentum Mean Streak (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0079, p = 0.660
  Step 2 (UCLA):        Delta R^2 = 0.0060, p = 0.310 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0028, p = 0.440 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -1.8203, SE = 1.7899, t = -1.02, p = 0.309

UCLA x Gender Interaction (Model 3):
  beta = 1.8251, SE = 2.3593, p = 0.439

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -3.5280, p = 0.134
  Male (n=82):   beta = 1.0193, p = 0.739

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.123
  Shapiro-Wilk p: < 0.001


Outcome: PRP Momentum Max Streak (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0088, p = 0.620
  Step 2 (UCLA):        Delta R^2 = 0.0046, p = 0.362 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0045, p = 0.319 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.8071, SE = 3.0727, t = -0.91, p = 0.361

UCLA x Gender Interaction (Model 3):
  beta = 4.1557, SE = 4.1575, p = 0.318

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -5.6994, p = 0.157
  Male (n=82):   beta = 1.4254, p = 0.790

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.139
  Shapiro-Wilk p: < 0.001


Outcome: PRP Volatility RMSSD (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0078, p = 0.651
  Step 2 (UCLA):        Delta R^2 = 0.0015, p = 0.609 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0134, p = 0.127 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.3744, SE = 12.4569, t = 0.51, p = 0.609

UCLA x Gender Interaction (Model 3):
  beta = 28.7033, SE = 18.7530, p = 0.126

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -1.5817, p = 0.920
  Male (n=82):   beta = 11.6241, p = 0.575

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.221
  Shapiro-Wilk p: 0.279


Outcome: PRP Volatility (Detrended SD) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0033, p = 0.872
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.555 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0043, p = 0.379 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.8360, SE = 8.1759, t = 0.59, p = 0.554

UCLA x Gender Interaction (Model 3):
  beta = 11.8816, SE = 13.4676, p = 0.378

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 2.5967, p = 0.804
  Male (n=82):   beta = 3.7550, p = 0.779

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.311
  Shapiro-Wilk p: 0.115


Outcome: PRP IIV Intercept (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0365, p = 0.050
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.739 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0128, p = 0.154 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -8.6871, SE = 26.0126, t = -0.33, p = 0.738

UCLA x Gender Interaction (Model 3):
  beta = 64.8024, SE = 45.3206, p = 0.153

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -14.9038, p = 0.651
  Male (n=82):   beta = -19.3614, p = 0.655

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.653
  Shapiro-Wilk p: < 0.001


Outcome: PRP IIV Slope (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0301, p = 0.106
  Step 2 (UCLA):        Delta R^2 = 0.0050, p = 0.303 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0090, p = 0.195 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 28.2249, SE = 27.3220, t = 1.03, p = 0.302

UCLA x Gender Interaction (Model 3):
  beta = -56.3364, SE = 43.3166, p = 0.193

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 46.4815, p = 0.202
  Male (n=82):   beta = 8.8412, p = 0.842

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.406
  Shapiro-Wilk p: 0.553


Outcome: PRP IIV Residual SD (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0034, p = 0.871
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.556 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0043, p = 0.379 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.8511, SE = 8.2199, t = 0.59, p = 0.555

UCLA x Gender Interaction (Model 3):
  beta = 11.9390, SE = 13.5409, p = 0.378

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 2.6022, p = 0.805
  Male (n=82):   beta = 3.7636, p = 0.780

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.311
  Shapiro-Wilk p: 0.115


Outcome: PRP IIV Raw CV (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0314, p = 0.094
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.830 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.902 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0013, SE = 0.0062, t = 0.21, p = 0.830

UCLA x Gender Interaction (Model 3):
  beta = -0.0012, SE = 0.0094, p = 0.902

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0023, p = 0.772
  Male (n=82):   beta = 0.0089, p = 0.443

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.702
  Shapiro-Wilk p: 0.158


Outcome: PRP IIV R-squared (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0212, p = 0.231
  Step 2 (UCLA):        Delta R^2 = 0.0046, p = 0.306 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.882 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0051, SE = 0.0050, t = -1.03, p = 0.305

UCLA x Gender Interaction (Model 3):
  beta = 0.0012, SE = 0.0083, p = 0.882

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0026, p = 0.670
  Male (n=82):   beta = -0.0105, p = 0.235

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.119
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error CV Reduction (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0626, p = 0.129
  Step 2 (UCLA):        Delta R^2 = 0.0069, p = 0.385 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.666 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0180, SE = 0.0206, t = -0.87, p = 0.383

UCLA x Gender Interaction (Model 3):
  beta = 0.0142, SE = 0.0327, p = 0.665

Gender-Stratified UCLA Effects:
  Female (n=54): beta = -0.0215, p = 0.328
  Male (n=37):   beta = -0.0143, p = 0.786

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.347
  Shapiro-Wilk p: 0.178


Outcome: PRP Post-Error Accuracy (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0283, p = 0.471
  Step 2 (UCLA):        Delta R^2 = 0.0152, p = 0.311 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0131, p = 0.389 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0197, SE = 0.0193, t = 1.02, p = 0.308

UCLA x Gender Interaction (Model 3):
  beta = -0.0272, SE = 0.0314, p = 0.386

Gender-Stratified UCLA Effects:
  Female (n=54): beta = 0.0301, p = 0.207
  Male (n=37):   beta = 0.0006, p = 0.986

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.313
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error Accuracy Diff (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0431, p = 0.272
  Step 2 (UCLA):        Delta R^2 = 0.0215, p = 0.221 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0165, p = 0.336 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0241, SE = 0.0195, t = 1.23, p = 0.218

UCLA x Gender Interaction (Model 3):
  beta = -0.0314, SE = 0.0325, p = 0.333

Gender-Stratified UCLA Effects:
  Female (n=54): beta = 0.0357, p = 0.130
  Male (n=37):   beta = 0.0051, p = 0.894

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.448
  Shapiro-Wilk p: < 0.001


Outcome: PRP Post-Error Recovery Rate (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0283, p = 0.471
  Step 2 (UCLA):        Delta R^2 = 0.0152, p = 0.311 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0131, p = 0.389 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0197, SE = 0.0193, t = 1.02, p = 0.308

UCLA x Gender Interaction (Model 3):
  beta = -0.0272, SE = 0.0314, p = 0.386

Gender-Stratified UCLA Effects:
  Female (n=54): beta = 0.0301, p = 0.207
  Male (n=37):   beta = 0.0006, p = 0.986

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.313
  Shapiro-Wilk p: < 0.001


Outcome: PRP Adaptive PES Flag (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0052, p = 0.927
  Step 2 (UCLA):        Delta R^2 = 0.0562, p = 0.022 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.743 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1570, SE = 0.0674, t = 2.33, p = 0.020

UCLA x Gender Interaction (Model 3):
  beta = -0.0372, SE = 0.1131, p = 0.742

Gender-Stratified UCLA Effects:
  Female (n=54): beta = 0.1279, p = 0.160
  Male (n=37):   beta = 0.1566, p = 0.245

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.287
  Shapiro-Wilk p: < 0.001


Outcome: PRP Maladaptive PES Flag (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0075, p = 0.880
  Step 2 (UCLA):        Delta R^2 = 0.0152, p = 0.271 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.890 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0748, SE = 0.0674, t = -1.11, p = 0.267

UCLA x Gender Interaction (Model 3):
  beta = 0.0151, SE = 0.1085, p = 0.889

Gender-Stratified UCLA Effects:
  Female (n=54): beta = -0.0769, p = 0.317
  Male (n=37):   beta = -0.0746, p = 0.576

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.784
  Shapiro-Wilk p: < 0.001


Outcome: PRP Error Awareness Index (N = 91)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0443, p = 0.272
  Step 2 (UCLA):        Delta R^2 = 0.0047, p = 0.553 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0060, p = 0.524 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0749, SE = 0.1257, t = 0.60, p = 0.551

UCLA x Gender Interaction (Model 3):
  beta = -0.1261, SE = 0.1972, p = 0.523

Gender-Stratified UCLA Effects:
  Female (n=54): beta = 0.1273, p = 0.420
  Male (n=37):   beta = -0.0263, p = 0.902

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.228
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Mean RT (All) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0208, p = 0.211
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.811 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0060, p = 0.343 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.4254, SE = 22.6673, t = 0.24, p = 0.811

UCLA x Gender Interaction (Model 3):
  beta = 36.6342, SE = 38.5428, p = 0.342

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 8.3369, p = 0.773
  Male (n=82):   beta = -14.9408, p = 0.702

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.883
  Shapiro-Wilk p: 0.002


Outcome: PRP T2 Accuracy (All) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0045, p = 0.827
  Step 2 (UCLA):        Delta R^2 = 0.0124, p = 0.153 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.692 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0035, SE = 0.0024, t = -1.43, p = 0.152

UCLA x Gender Interaction (Model 3):
  beta = 0.0011, SE = 0.0029, p = 0.691

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0046, p = 0.130
  Male (n=82):   beta = -0.0011, p = 0.782

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.614
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Error Rate (All) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0045, p = 0.827
  Step 2 (UCLA):        Delta R^2 = 0.0124, p = 0.153 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.692 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0035, SE = 0.0024, t = 1.43, p = 0.152

UCLA x Gender Interaction (Model 3):
  beta = -0.0011, SE = 0.0029, p = 0.691

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0046, p = 0.130
  Male (n=82):   beta = 0.0011, p = 0.782

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.614
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Inverse Efficiency Score (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0216, p = 0.195
  Step 2 (UCLA):        Delta R^2 = 0.0008, p = 0.693 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0057, p = 0.357 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 9.0698, SE = 22.9652, t = 0.39, p = 0.693

UCLA x Gender Interaction (Model 3):
  beta = 36.3808, SE = 39.3738, p = 0.355

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 13.4340, p = 0.653
  Male (n=82):   beta = -14.7131, p = 0.704

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.848
  Shapiro-Wilk p: 0.001


Outcome: PRP Pre-Error RT Slope (Mean) (N = 92)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.1225, p = 0.009
  Step 2 (UCLA):        Delta R^2 = 0.0130, p = 0.342 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.892 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -21.9031, SE = 22.9329, t = -0.96, p = 0.340

UCLA x Gender Interaction (Model 3):
  beta = -4.9231, SE = 36.1103, p = 0.892

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -22.3244, p = 0.492
  Male (n=36):   beta = -13.4213, p = 0.620

Diagnostics:
  VIF max: 2.58
  Breusch-Pagan p: 0.314
  Shapiro-Wilk p: 0.007


Outcome: PRP Pre-Error RT Slope (SD) (N = 92)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0083, p = 0.862
  Step 2 (UCLA):        Delta R^2 = 0.0047, p = 0.571 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.883 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -10.9799, SE = 19.2871, t = -0.57, p = 0.569

UCLA x Gender Interaction (Model 3):
  beta = -4.3175, SE = 29.1654, p = 0.882

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -28.1278, p = 0.150
  Male (n=36):   beta = 13.3970, p = 0.735

Diagnostics:
  VIF max: 2.58
  Breusch-Pagan p: 0.432
  Shapiro-Wilk p: < 0.001


Outcome: PRP Pre-Error Events (N) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0042, p = 0.839
  Step 2 (UCLA):        Delta R^2 = 0.0121, p = 0.150 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0015, p = 0.525 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.3967, SE = 0.2745, t = 1.44, p = 0.148

UCLA x Gender Interaction (Model 3):
  beta = -0.2059, SE = 0.3235, p = 0.525

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.5684, p = 0.101
  Male (n=82):   beta = 0.0738, p = 0.873

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.760
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery RT Lag1 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0501, p = 0.163
  Step 2 (UCLA):        Delta R^2 = 0.0061, p = 0.449 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0214, p = 0.153 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 36.6918, SE = 48.2880, t = 0.76, p = 0.447

UCLA x Gender Interaction (Model 3):
  beta = 101.4254, SE = 70.3847, p = 0.150

Gender-Stratified UCLA Effects:
  Female (n=56): beta = 10.0051, p = 0.869
  Male (n=39):   beta = 7.0898, p = 0.918

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.056
  Shapiro-Wilk p: 0.072


Outcome: PRP Recovery RT Lag2 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0512, p = 0.161
  Step 2 (UCLA):        Delta R^2 = 0.0083, p = 0.369 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.631 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -37.0718, SE = 41.0960, t = -0.90, p = 0.367

UCLA x Gender Interaction (Model 3):
  beta = -30.1205, SE = 62.4091, p = 0.629

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -26.2978, p = 0.609
  Male (n=39):   beta = -104.6359, p = 0.193

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.089
  Shapiro-Wilk p: 0.571


Outcome: PRP Recovery RT Lag3 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0836, p = 0.042
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.932 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0182, p = 0.248 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.8044, SE = 44.5624, t = 0.09, p = 0.932

UCLA x Gender Interaction (Model 3):
  beta = 80.2191, SE = 68.9435, p = 0.245

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -47.8464, p = 0.191
  Male (n=39):   beta = -0.9872, p = 0.990

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.344
  Shapiro-Wilk p: 0.042


Outcome: PRP Recovery RT Lag4 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0522, p = 0.167
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.747 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0689, p = 0.038 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 14.9987, SE = 46.2576, t = 0.32, p = 0.746

UCLA x Gender Interaction (Model 3):
  beta = 164.8500, SE = 78.0542, p = 0.035

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -17.7052, p = 0.700
  Male (n=39):   beta = -0.9030, p = 0.992

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.632
  Shapiro-Wilk p: 0.076


Outcome: PRP Recovery RT Lag5 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0512, p = 0.181
  Step 2 (UCLA):        Delta R^2 = 0.0025, p = 0.629 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0585, p = 0.026 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -21.1120, SE = 43.5457, t = -0.48, p = 0.628

UCLA x Gender Interaction (Model 3):
  beta = 150.7692, SE = 66.5880, p = 0.024

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -84.6334, p = 0.072
  Male (n=39):   beta = 50.4193, p = 0.579

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.921
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag1 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0335, p = 0.373
  Step 2 (UCLA):        Delta R^2 = 0.0252, p = 0.177 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0050, p = 0.593 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0265, SE = 0.0195, t = 1.36, p = 0.173

UCLA x Gender Interaction (Model 3):
  beta = -0.0174, SE = 0.0325, p = 0.592

Gender-Stratified UCLA Effects:
  Female (n=56): beta = 0.0319, p = 0.152
  Male (n=39):   beta = 0.0250, p = 0.556

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.395
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag2 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0111, p = 0.800
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.611 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0051, p = 0.390 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0038, SE = 0.0075, t = 0.51, p = 0.610

UCLA x Gender Interaction (Model 3):
  beta = -0.0082, SE = 0.0095, p = 0.388

Gender-Stratified UCLA Effects:
  Female (n=56): beta = 0.0097, p = 0.357
  Male (n=39):   beta = -0.0086, p = 0.415

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.855
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag3 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0027, p = 0.971
  Step 2 (UCLA):        Delta R^2 = 0.0039, p = 0.584 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0353, p = 0.181 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0075, SE = 0.0137, t = -0.55, p = 0.583

UCLA x Gender Interaction (Model 3):
  beta = -0.0337, SE = 0.0250, p = 0.178

Gender-Stratified UCLA Effects:
  Female (n=56): beta = 0.0055, p = 0.683
  Male (n=39):   beta = -0.0313, p = 0.399

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.464
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag4 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0096, p = 0.828
  Step 2 (UCLA):        Delta R^2 = 0.0162, p = 0.279 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.608 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0130, SE = 0.0119, t = 1.09, p = 0.276

UCLA x Gender Interaction (Model 3):
  beta = -0.0075, SE = 0.0145, p = 0.607

Gender-Stratified UCLA Effects:
  Female (n=56): beta = 0.0166, p = 0.342
  Male (n=39):   beta = 0.0090, p = 0.307

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.897
  Shapiro-Wilk p: < 0.001


Outcome: PRP Recovery Accuracy Lag5 (N = 95)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0277, p = 0.462
  Step 2 (UCLA):        Delta R^2 = 0.0415, p = 0.065 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.616 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0163, SE = 0.0087, t = -1.87, p = 0.062

UCLA x Gender Interaction (Model 3):
  beta = 0.0054, SE = 0.0107, p = 0.615

Gender-Stratified UCLA Effects:
  Female (n=56): beta = -0.0213, p = 0.085
  Male (n=39):   beta = -0.0082, p = 0.556

Diagnostics:
  VIF max: 2.56
  Breusch-Pagan p: 0.245
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Mean RT (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0193, p = 0.238
  Step 2 (UCLA):        Delta R^2 = 0.0030, p = 0.453 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0125, p = 0.173 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 19.9861, SE = 26.5750, t = 0.75, p = 0.452

UCLA x Gender Interaction (Model 3):
  beta = 60.6022, SE = 44.3253, p = 0.172

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 18.0271, p = 0.593
  Male (n=82):   beta = 1.4959, p = 0.972

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.411
  Shapiro-Wilk p: 0.002


Outcome: PRP T2 Mean RT (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0116, p = 0.469
  Step 2 (UCLA):        Delta R^2 = 0.0033, p = 0.424 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0064, p = 0.329 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 20.9964, SE = 26.2329, t = 0.80, p = 0.423

UCLA x Gender Interaction (Model 3):
  beta = 43.6061, SE = 44.5216, p = 0.327

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 20.8005, p = 0.517
  Male (n=82):   beta = 1.2569, p = 0.978

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.937
  Shapiro-Wilk p: 0.008


Outcome: PRP T2 Mean RT (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0197, p = 0.233
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.841 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0053, p = 0.347 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.5867, SE = 27.8335, t = -0.20, p = 0.841

UCLA x Gender Interaction (Model 3):
  beta = 41.9842, SE = 44.5617, p = 0.346

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -2.3790, p = 0.947
  Male (n=82):   beta = -26.6593, p = 0.592

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.884
  Shapiro-Wilk p: 0.009


Outcome: PRP T2 Mean RT (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0255, p = 0.143
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.995 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0028, p = 0.502 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.1425, SE = 23.4121, t = 0.01, p = 0.995

UCLA x Gender Interaction (Model 3):
  beta = 26.1869, SE = 38.9378, p = 0.501

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 7.3707, p = 0.805
  Male (n=82):   beta = -24.1655, p = 0.556

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.969
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Mean RT (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0284, p = 0.117
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.843 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.660 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.3804, SE = 17.0993, t = -0.20, p = 0.843

UCLA x Gender Interaction (Model 3):
  beta = 13.8190, SE = 31.4146, p = 0.660

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 1.9852, p = 0.929
  Male (n=82):   beta = -19.7412, p = 0.509

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.692
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Median RT (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0205, p = 0.213
  Step 2 (UCLA):        Delta R^2 = 0.0033, p = 0.450 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0180, p = 0.113 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 21.6161, SE = 28.5421, t = 0.76, p = 0.449

UCLA x Gender Interaction (Model 3):
  beta = 75.0291, SE = 47.0902, p = 0.111

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 17.1623, p = 0.641
  Male (n=82):   beta = 1.3360, p = 0.976

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.583
  Shapiro-Wilk p: 0.002


Outcome: PRP T2 Median RT (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0130, p = 0.422
  Step 2 (UCLA):        Delta R^2 = 0.0052, p = 0.326 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0109, p = 0.211 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 28.4556, SE = 28.8705, t = 0.99, p = 0.324

UCLA x Gender Interaction (Model 3):
  beta = 61.3703, SE = 48.9031, p = 0.210

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 22.2469, p = 0.516
  Male (n=82):   beta = 14.2151, p = 0.782

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.942
  Shapiro-Wilk p: 0.003


Outcome: PRP T2 Median RT (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0228, p = 0.174
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.875 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0041, p = 0.434 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.8885, SE = 31.0198, t = -0.16, p = 0.875

UCLA x Gender Interaction (Model 3):
  beta = 38.9788, SE = 49.6934, p = 0.433

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.3058, p = 0.994
  Male (n=82):   beta = -28.9703, p = 0.621

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.609
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Median RT (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0288, p = 0.110
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.951 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0023, p = 0.554 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 1.4415, SE = 23.2935, t = 0.06, p = 0.951

UCLA x Gender Interaction (Model 3):
  beta = 23.8151, SE = 40.1438, p = 0.553

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 18.1315, p = 0.546
  Male (n=82):   beta = -40.1628, p = 0.337

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.915
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 Median RT (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0336, p = 0.073
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.769 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0025, p = 0.582 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 4.4655, SE = 15.2112, t = 0.29, p = 0.769

UCLA x Gender Interaction (Model 3):
  beta = 15.8583, SE = 28.7901, p = 0.582

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 6.7105, p = 0.733
  Male (n=82):   beta = -4.9931, p = 0.852

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.303
  Shapiro-Wilk p: < 0.001


Outcome: PRP T2 RT SD (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0041, p = 0.842
  Step 2 (UCLA):        Delta R^2 = 0.0024, p = 0.479 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.869 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.4500, SE = 10.5077, t = 0.71, p = 0.478

UCLA x Gender Interaction (Model 3):
  beta = 2.7853, SE = 16.8699, p = 0.869

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 10.4007, p = 0.442
  Male (n=82):   beta = -0.9506, p = 0.956

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.654
  Shapiro-Wilk p: 0.055


Outcome: PRP T2 RT SD (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0021, p = 0.936
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.750 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0004, p = 0.794 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.4160, SE = 10.7055, t = 0.32, p = 0.750

UCLA x Gender Interaction (Model 3):
  beta = 4.9005, SE = 18.7523, p = 0.794

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 3.3085, p = 0.802
  Male (n=82):   beta = -0.4719, p = 0.980

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.240
  Shapiro-Wilk p: 0.008


Outcome: PRP T2 RT SD (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0255, p = 0.159
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.774 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.725 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.1332, SE = 10.8736, t = -0.29, p = 0.773

UCLA x Gender Interaction (Model 3):
  beta = 5.7124, SE = 16.1874, p = 0.724

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.1006, p = 0.994
  Male (n=82):   beta = -11.6856, p = 0.534

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.600
  Shapiro-Wilk p: 0.118


Outcome: PRP T2 RT SD (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0163, p = 0.339
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.809 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0016, p = 0.580 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.1906, SE = 13.1711, t = 0.24, p = 0.809

UCLA x Gender Interaction (Model 3):
  beta = 11.1248, SE = 20.0724, p = 0.579

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -3.3209, p = 0.844
  Male (n=82):   beta = 11.3722, p = 0.597

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.171
  Shapiro-Wilk p: 0.061


Outcome: PRP T2 RT SD (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0102, p = 0.554
  Step 2 (UCLA):        Delta R^2 = 0.0031, p = 0.387 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.739 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -8.9907, SE = 10.3670, t = -0.87, p = 0.386

UCLA x Gender Interaction (Model 3):
  beta = 5.7907, SE = 17.3585, p = 0.739

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -5.6527, p = 0.690
  Male (n=82):   beta = -18.2231, p = 0.270

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.825
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0108, p = 0.527
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.892 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0184, p = 0.174 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.0931, SE = 22.7110, t = 0.14, p = 0.892

UCLA x Gender Interaction (Model 3):
  beta = 62.4188, SE = 45.7224, p = 0.172

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 2.6740, p = 0.918
  Male (n=82):   beta = -15.3865, p = 0.751

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.001
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0067, p = 0.707
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.869 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0156, p = 0.205 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 3.8927, SE = 23.6214, t = 0.16, p = 0.869

UCLA x Gender Interaction (Model 3):
  beta = 58.1334, SE = 45.6972, p = 0.203

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 1.2448, p = 0.962
  Male (n=82):   beta = -13.3622, p = 0.791

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.055
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0134, p = 0.427
  Step 2 (UCLA):        Delta R^2 = 0.0028, p = 0.465 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0132, p = 0.220 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -17.9474, SE = 24.4990, t = -0.73, p = 0.464

UCLA x Gender Interaction (Model 3):
  beta = 57.6777, SE = 46.8714, p = 0.218

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -18.8963, p = 0.522
  Male (n=82):   beta = -33.1845, p = 0.521

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.226
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0133, p = 0.441
  Step 2 (UCLA):        Delta R^2 = 0.0043, p = 0.382 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0155, p = 0.173 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -22.8848, SE = 26.1341, t = -0.88, p = 0.381

UCLA x Gender Interaction (Model 3):
  beta = 64.4244, SE = 47.0560, p = 0.171

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -24.6048, p = 0.427
  Male (n=82):   beta = -39.2166, p = 0.476

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.109
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Mean RT (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0068, p = 0.717
  Step 2 (UCLA):        Delta R^2 = 0.0116, p = 0.117 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0051, p = 0.425 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -52.2561, SE = 33.2029, t = -1.57, p = 0.116

UCLA x Gender Interaction (Model 3):
  beta = 51.1869, SE = 63.9753, p = 0.424

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -36.7570, p = 0.377
  Male (n=82):   beta = -98.4474, p = 0.161

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.144
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0132, p = 0.434
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 1.000 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0232, p = 0.135 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0034, SE = 23.7577, t = 0.00, p = 1.000

UCLA x Gender Interaction (Model 3):
  beta = 71.9477, SE = 47.9563, p = 0.134

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -5.8233, p = 0.828
  Male (n=82):   beta = -11.7352, p = 0.818

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.004
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0137, p = 0.419
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.830 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0171, p = 0.201 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.3897, SE = 25.0091, t = 0.22, p = 0.829

UCLA x Gender Interaction (Model 3):
  beta = 64.2148, SE = 50.0457, p = 0.199

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 4.6978, p = 0.866
  Male (n=82):   beta = -18.0434, p = 0.736

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.080
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0118, p = 0.485
  Step 2 (UCLA):        Delta R^2 = 0.0036, p = 0.435 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0159, p = 0.183 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -21.4493, SE = 27.4332, t = -0.78, p = 0.434

UCLA x Gender Interaction (Model 3):
  beta = 66.9185, SE = 50.0436, p = 0.181

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -27.3873, p = 0.388
  Male (n=82):   beta = -30.5429, p = 0.595

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.383
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0160, p = 0.355
  Step 2 (UCLA):        Delta R^2 = 0.0077, p = 0.248 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0114, p = 0.267 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -32.0451, SE = 27.6809, t = -1.16, p = 0.247

UCLA x Gender Interaction (Model 3):
  beta = 58.0291, SE = 52.1698, p = 0.266

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -24.2910, p = 0.454
  Male (n=82):   beta = -62.8501, p = 0.307

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.123
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Median RT (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0071, p = 0.702
  Step 2 (UCLA):        Delta R^2 = 0.0104, p = 0.131 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.491 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -52.6832, SE = 34.7794, t = -1.51, p = 0.130

UCLA x Gender Interaction (Model 3):
  beta = 44.6957, SE = 64.7129, p = 0.490

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -34.0869, p = 0.442
  Male (n=82):   beta = -104.0311, p = 0.147

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.190
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 RT SD (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0065, p = 0.725
  Step 2 (UCLA):        Delta R^2 = 0.0015, p = 0.562 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0039, p = 0.407 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.5852, SE = 9.6229, t = 0.58, p = 0.562

UCLA x Gender Interaction (Model 3):
  beta = 13.2474, SE = 15.9431, p = 0.406

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 6.1170, p = 0.618
  Male (n=82):   beta = -0.9383, p = 0.955

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.256
  Shapiro-Wilk p: 0.028


Outcome: PRP T1 RT SD (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0013, p = 0.965
  Step 2 (UCLA):        Delta R^2 = 0.0017, p = 0.544 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0091, p = 0.233 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.5218, SE = 9.0764, t = 0.61, p = 0.543

UCLA x Gender Interaction (Model 3):
  beta = 19.1302, SE = 16.0040, p = 0.232

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.6672, p = 0.951
  Male (n=82):   beta = 11.1602, p = 0.509

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.277
  Shapiro-Wilk p: 0.008


Outcome: PRP T1 RT SD (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0291, p = 0.115
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.852 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0031, p = 0.411 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 1.8020, SE = 9.6185, t = 0.19, p = 0.851

UCLA x Gender Interaction (Model 3):
  beta = 12.5198, SE = 15.1827, p = 0.410

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 2.8275, p = 0.820
  Male (n=82):   beta = -2.4353, p = 0.886

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.490
  Shapiro-Wilk p: 0.023


Outcome: PRP T1 RT SD (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0133, p = 0.435
  Step 2 (UCLA):        Delta R^2 = 0.0011, p = 0.668 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0108, p = 0.167 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.4752, SE = 12.7633, t = 0.43, p = 0.668

UCLA x Gender Interaction (Model 3):
  beta = 24.9921, SE = 18.0179, p = 0.165

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -6.1286, p = 0.710
  Male (n=82):   beta = 19.0464, p = 0.334

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.426
  Shapiro-Wilk p: 0.332


Outcome: PRP T1 RT SD (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0133, p = 0.445
  Step 2 (UCLA):        Delta R^2 = 0.0081, p = 0.205 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.803 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -17.6876, SE = 13.9125, t = -1.27, p = 0.204

UCLA x Gender Interaction (Model 3):
  beta = -5.3658, SE = 21.4949, p = 0.803

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -18.9230, p = 0.284
  Male (n=82):   beta = -15.3805, p = 0.521

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.089
  Shapiro-Wilk p: 0.005


Outcome: PRP T1 Accuracy (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0083, p = 0.646
  Step 2 (UCLA):        Delta R^2 = 0.0074, p = 0.201 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0054, p = 0.320 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0044, SE = 0.0034, t = -1.28, p = 0.199

UCLA x Gender Interaction (Model 3):
  beta = -0.0056, SE = 0.0056, p = 0.319

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0022, p = 0.627
  Male (n=82):   beta = -0.0078, p = 0.189

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.522
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0105, p = 0.549
  Step 2 (UCLA):        Delta R^2 = 0.0002, p = 0.862 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0237, p = 0.046 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0007, SE = 0.0043, t = -0.17, p = 0.862

UCLA x Gender Interaction (Model 3):
  beta = -0.0132, SE = 0.0066, p = 0.044

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0028, p = 0.588
  Male (n=82):   beta = -0.0043, p = 0.582

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.135
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0124, p = 0.463
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.733 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0034, p = 0.420 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0011, SE = 0.0034, t = 0.34, p = 0.733

UCLA x Gender Interaction (Model 3):
  beta = -0.0038, SE = 0.0047, p = 0.419

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0018, p = 0.711
  Male (n=82):   beta = 0.0010, p = 0.840

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.315
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0239, p = 0.180
  Step 2 (UCLA):        Delta R^2 = 0.0028, p = 0.456 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.924 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0023, SE = 0.0030, t = 0.75, p = 0.455

UCLA x Gender Interaction (Model 3):
  beta = -0.0004, SE = 0.0046, p = 0.924

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0019, p = 0.687
  Male (n=82):   beta = 0.0039, p = 0.247

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.403
  Shapiro-Wilk p: < 0.001


Outcome: PRP T1 Accuracy (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0502, p = 0.015
  Step 2 (UCLA):        Delta R^2 = 0.0060, p = 0.339 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.934 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0027, SE = 0.0028, t = -0.96, p = 0.338

UCLA x Gender Interaction (Model 3):
  beta = -0.0003, SE = 0.0041, p = 0.934

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0016, p = 0.662
  Male (n=82):   beta = -0.0033, p = 0.485

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.355
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 50) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0106, p = 0.528
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.749 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0058, p = 0.246 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0023, SE = 0.0073, t = 0.32, p = 0.749

UCLA x Gender Interaction (Model 3):
  beta = 0.0135, SE = 0.0116, p = 0.245

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0034, p = 0.694
  Male (n=82):   beta = -0.0047, p = 0.734

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.615
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 150) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0177, p = 0.309
  Step 2 (UCLA):        Delta R^2 = 0.0047, p = 0.342 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0320, p = 0.003 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0103, SE = 0.0108, t = -0.95, p = 0.341

UCLA x Gender Interaction (Model 3):
  beta = 0.0400, SE = 0.0131, p = 0.002

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0257, p = 0.068
  Male (n=82):   beta = 0.0065, p = 0.640

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.573
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 300) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0061, p = 0.749
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.936 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0194, p = 0.040 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0006, SE = 0.0080, t = -0.08, p = 0.936

UCLA x Gender Interaction (Model 3):
  beta = 0.0242, SE = 0.0117, p = 0.039

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0024, p = 0.813
  Male (n=82):   beta = -0.0048, p = 0.714

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.942
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 600) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0197, p = 0.248
  Step 2 (UCLA):        Delta R^2 = 0.0040, p = 0.378 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0660, p = < 0.001 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0108, SE = 0.0122, t = -0.88, p = 0.377

UCLA x Gender Interaction (Model 3):
  beta = 0.0651, SE = 0.0176, p = < 0.001

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0335, p = 0.017
  Male (n=82):   beta = 0.0160, p = 0.506

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.013
  Shapiro-Wilk p: < 0.001


Outcome: PRP RT1-RT2 Coupling (SOA 1200) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0250, p = 0.167
  Step 2 (UCLA):        Delta R^2 = 0.0172, p = 0.043 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.693 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0490, SE = 0.0241, t = -2.04, p = 0.042

UCLA x Gender Interaction (Model 3):
  beta = 0.0149, SE = 0.0376, p = 0.693

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0476, p = 0.094
  Male (n=82):   beta = -0.0522, p = 0.294

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.626
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (short, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0211, p = 0.204
  Step 2 (UCLA):        Delta R^2 = 0.0089, p = 0.226 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0075, p = 0.336 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 38.7402, SE = 31.8692, t = 1.22, p = 0.224

UCLA x Gender Interaction (Model 3):
  beta = 52.9574, SE = 54.8693, p = 0.334

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 37.5755, p = 0.351
  Male (n=82):   beta = 18.1719, p = 0.745

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.632
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (short, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0201, p = 0.235
  Step 2 (UCLA):        Delta R^2 = 0.0183, p = 0.079 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0056, p = 0.341 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 21.6335, SE = 12.2373, t = 1.77, p = 0.077

UCLA x Gender Interaction (Model 3):
  beta = 17.8302, SE = 18.6995, p = 0.340

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 18.5074, p = 0.264
  Male (n=82):   beta = 19.2710, p = 0.285

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.568
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (short, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0245, p = 0.174
  Step 2 (UCLA):        Delta R^2 = 0.0061, p = 0.300 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.909 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -17.8491, SE = 17.1827, t = -1.04, p = 0.299

UCLA x Gender Interaction (Model 3):
  beta = 3.0053, SE = 26.1886, p = 0.909

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -19.4469, p = 0.379
  Male (n=82):   beta = -13.7969, p = 0.644

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.735
  Shapiro-Wilk p: 0.453


Outcome: PRP Ex-Gaussian mu (long, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0320, p = 0.101
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.615 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0051, p = 0.403 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.4459, SE = 12.7812, t = 0.50, p = 0.614

UCLA x Gender Interaction (Model 3):
  beta = 19.2138, SE = 22.9366, p = 0.402

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 4.4523, p = 0.794
  Male (n=80):   beta = 1.9090, p = 0.925

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.410
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (long, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0382, p = 0.060
  Step 2 (UCLA):        Delta R^2 = 0.0037, p = 0.379 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.521 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.0384, SE = 5.7169, t = 0.88, p = 0.378

UCLA x Gender Interaction (Model 3):
  beta = 5.6577, SE = 8.8066, p = 0.521

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 0.7859, p = 0.917
  Male (n=80):   beta = 9.6943, p = 0.282

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.795
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (long, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0195, p = 0.286
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.578 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.911 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -7.3510, SE = 13.1915, t = -0.56, p = 0.577

UCLA x Gender Interaction (Model 3):
  beta = 2.3700, SE = 21.1455, p = 0.911

Gender-Stratified UCLA Effects:
  Female (n=114): beta = -3.3205, p = 0.850
  Male (n=80):   beta = -16.7036, p = 0.436

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.866
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (overall, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0327, p = 0.071
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.908 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0018, p = 0.638 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -3.2400, SE = 27.9012, t = -0.12, p = 0.908

UCLA x Gender Interaction (Model 3):
  beta = 22.8649, SE = 48.5600, p = 0.638

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 6.2358, p = 0.852
  Male (n=82):   beta = -29.8732, p = 0.608

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.430
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (overall, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0213, p = 0.202
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.938 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0016, p = 0.644 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 1.1428, SE = 14.5604, t = 0.08, p = 0.937

UCLA x Gender Interaction (Model 3):
  beta = 11.4742, SE = 24.7608, p = 0.643

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 3.9671, p = 0.829
  Male (n=82):   beta = -8.7936, p = 0.752

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.293
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (overall, correct) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0187, p = 0.287
  Step 2 (UCLA):        Delta R^2 = 0.0022, p = 0.518 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0024, p = 0.537 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 9.4673, SE = 14.6251, t = 0.65, p = 0.517

UCLA x Gender Interaction (Model 3):
  beta = 14.9231, SE = 24.1120, p = 0.536

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 2.1328, p = 0.901
  Male (n=82):   beta = 16.8525, p = 0.569

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.826
  Shapiro-Wilk p: 0.492


Outcome: PRP Ex-Gaussian mu (SOA 50) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0425, p = 0.028
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.982 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0120, p = 0.215 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.7259, SE = 32.6761, t = -0.02, p = 0.982

UCLA x Gender Interaction (Model 3):
  beta = 70.5138, SE = 56.6704, p = 0.213

Gender-Stratified UCLA Effects:
  Female (n=119): beta = 5.3237, p = 0.897
  Male (n=77):   beta = -44.9197, p = 0.391

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.024
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 50) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0534, p = 0.012
  Step 2 (UCLA):        Delta R^2 = 0.0054, p = 0.332 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0115, p = 0.143 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 13.8505, SE = 14.2481, t = 0.97, p = 0.331

UCLA x Gender Interaction (Model 3):
  beta = 29.8836, SE = 20.3353, p = 0.142

Gender-Stratified UCLA Effects:
  Female (n=119): beta = 16.1234, p = 0.382
  Male (n=77):   beta = -6.4872, p = 0.732

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.158
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 50) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0374, p = 0.062
  Step 2 (UCLA):        Delta R^2 = 0.0004, p = 0.778 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.920 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.0279, SE = 17.8246, t = 0.28, p = 0.778

UCLA x Gender Interaction (Model 3):
  beta = -2.5320, SE = 25.2004, p = 0.920

Gender-Stratified UCLA Effects:
  Female (n=119): beta = -1.9264, p = 0.932
  Male (n=77):   beta = 26.5133, p = 0.396

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.543
  Shapiro-Wilk p: 0.011


Outcome: PRP Ex-Gaussian mu (SOA 150) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0177, p = 0.318
  Step 2 (UCLA):        Delta R^2 = 0.0055, p = 0.359 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0087, p = 0.309 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 32.1471, SE = 34.9589, t = 0.92, p = 0.358

UCLA x Gender Interaction (Model 3):
  beta = 60.5607, SE = 59.4055, p = 0.308

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 23.1734, p = 0.571
  Male (n=79):   beta = 17.4025, p = 0.783

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.984
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 150) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0080, p = 0.672
  Step 2 (UCLA):        Delta R^2 = 0.0189, p = 0.073 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0005, p = 0.795 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 25.9008, SE = 14.3633, t = 1.80, p = 0.071

UCLA x Gender Interaction (Model 3):
  beta = 6.3109, SE = 24.2836, p = 0.795

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 26.0923, p = 0.174
  Male (n=79):   beta = 17.5268, p = 0.406

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.705
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 150) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0045, p = 0.837
  Step 2 (UCLA):        Delta R^2 = 0.0025, p = 0.503 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0000, p = 0.936 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -12.9412, SE = 19.2911, t = -0.67, p = 0.502

UCLA x Gender Interaction (Model 3):
  beta = -2.4350, SE = 30.3707, p = 0.936

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -11.0430, p = 0.656
  Male (n=79):   beta = -12.5597, p = 0.696

Diagnostics:
  VIF max: 2.62
  Breusch-Pagan p: 0.534
  Shapiro-Wilk p: 0.002


Outcome: PRP Ex-Gaussian mu (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0501, p = 0.014
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.705 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0048, p = 0.402 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -12.3858, SE = 32.7192, t = -0.38, p = 0.705

UCLA x Gender Interaction (Model 3):
  beta = 42.3599, SE = 50.4851, p = 0.401

Gender-Stratified UCLA Effects:
  Female (n=121): beta = -16.2809, p = 0.672
  Male (n=80):   beta = -20.0287, p = 0.753

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.077
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0460, p = 0.025
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.759 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0037, p = 0.437 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.2023, SE = 13.6853, t = -0.31, p = 0.759

UCLA x Gender Interaction (Model 3):
  beta = 17.0449, SE = 21.8776, p = 0.436

Gender-Stratified UCLA Effects:
  Female (n=121): beta = -7.9178, p = 0.659
  Male (n=80):   beta = -3.7074, p = 0.871

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.096
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 300) (N = 201)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0277, p = 0.133
  Step 2 (UCLA):        Delta R^2 = 0.0009, p = 0.678 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0014, p = 0.607 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.0092, SE = 16.8561, t = 0.42, p = 0.678

UCLA x Gender Interaction (Model 3):
  beta = 12.6783, SE = 24.5942, p = 0.606

Gender-Stratified UCLA Effects:
  Female (n=121): beta = 6.0818, p = 0.775
  Male (n=80):   beta = 6.6900, p = 0.833

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.352
  Shapiro-Wilk p: 0.233


Outcome: PRP Ex-Gaussian mu (SOA 600) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0206, p = 0.250
  Step 2 (UCLA):        Delta R^2 = 0.0098, p = 0.121 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0104, p = 0.235 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -26.3405, SE = 16.9003, t = -1.56, p = 0.119

UCLA x Gender Interaction (Model 3):
  beta = 40.3683, SE = 33.9122, p = 0.234

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -22.7587, p = 0.323
  Male (n=80):   beta = -46.7512, p = 0.098

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.123
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 600) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0064, p = 0.747
  Step 2 (UCLA):        Delta R^2 = 0.0192, p = 0.028 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.600 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -19.3082, SE = 8.7225, t = -2.21, p = 0.027

UCLA x Gender Interaction (Model 3):
  beta = 9.6339, SE = 18.3607, p = 0.600

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -13.1968, p = 0.279
  Male (n=80):   beta = -35.7122, p = 0.016

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.194
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 600) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0232, p = 0.208
  Step 2 (UCLA):        Delta R^2 = 0.0069, p = 0.271 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.810 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 17.1631, SE = 15.5387, t = 1.10, p = 0.269

UCLA x Gender Interaction (Model 3):
  beta = 5.6006, SE = 23.2540, p = 0.810

Gender-Stratified UCLA Effects:
  Female (n=116): beta = 9.9356, p = 0.600
  Male (n=80):   beta = 26.2456, p = 0.333

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.650
  Shapiro-Wilk p: 0.163


Outcome: PRP Ex-Gaussian mu (SOA 1200) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0357, p = 0.072
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.938 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0045, p = 0.413 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.9899, SE = 12.7102, t = 0.08, p = 0.938

UCLA x Gender Interaction (Model 3):
  beta = 18.1277, SE = 22.1003, p = 0.412

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -2.0273, p = 0.904
  Male (n=80):   beta = -0.1772, p = 0.993

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.731
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 1200) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0382, p = 0.058
  Step 2 (UCLA):        Delta R^2 = 0.0010, p = 0.628 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0007, p = 0.705 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 2.6721, SE = 5.4980, t = 0.49, p = 0.627

UCLA x Gender Interaction (Model 3):
  beta = 3.3020, SE = 8.6978, p = 0.704

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.2669, p = 0.865
  Male (n=80):   beta = 7.8906, p = 0.371

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.807
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 1200) (N = 196)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0166, p = 0.354
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.749 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0008, p = 0.707 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -4.1751, SE = 13.0406, t = -0.32, p = 0.749

UCLA x Gender Interaction (Model 3):
  beta = 7.8187, SE = 20.7414, p = 0.706

Gender-Stratified UCLA Effects:
  Female (n=116): beta = -1.7461, p = 0.919
  Male (n=80):   beta = -14.2027, p = 0.505

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.682
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian mu (SOA 50, correct) (N = 191)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0479, p = 0.019
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.824 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0105, p = 0.254 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.4123, SE = 33.2671, t = 0.22, p = 0.824

UCLA x Gender Interaction (Model 3):
  beta = 66.4813, SE = 58.0933, p = 0.252

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 12.8536, p = 0.763
  Male (n=76):   beta = -37.9136, p = 0.468

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.029
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 50, correct) (N = 191)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0592, p = 0.009
  Step 2 (UCLA):        Delta R^2 = 0.0065, p = 0.275 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0095, p = 0.182 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 15.4817, SE = 14.1417, t = 1.09, p = 0.274

UCLA x Gender Interaction (Model 3):
  beta = 27.6739, SE = 20.6333, p = 0.180

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 15.8928, p = 0.385
  Male (n=76):   beta = -2.5061, p = 0.895

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.602
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 50, correct) (N = 191)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0423, p = 0.045
  Step 2 (UCLA):        Delta R^2 = 0.0001, p = 0.899 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.865 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -2.2933, SE = 17.9985, t = -0.13, p = 0.899

UCLA x Gender Interaction (Model 3):
  beta = 4.3721, SE = 25.6908, p = 0.865

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -10.8789, p = 0.632
  Male (n=76):   beta = 22.8871, p = 0.481

Diagnostics:
  VIF max: 2.60
  Breusch-Pagan p: 0.565
  Shapiro-Wilk p: 0.013


Outcome: PRP Ex-Gaussian mu (SOA 150, correct) (N = 190)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0174, p = 0.339
  Step 2 (UCLA):        Delta R^2 = 0.0073, p = 0.296 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0080, p = 0.333 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 37.6907, SE = 35.9336, t = 1.05, p = 0.294

UCLA x Gender Interaction (Model 3):
  beta = 58.1321, SE = 59.8423, p = 0.331

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 28.2568, p = 0.512
  Male (n=77):   beta = 19.5245, p = 0.764

Diagnostics:
  VIF max: 2.63
  Breusch-Pagan p: 0.985
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 150, correct) (N = 190)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0063, p = 0.758
  Step 2 (UCLA):        Delta R^2 = 0.0305, p = 0.023 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.914 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 33.4714, SE = 14.5482, t = 2.30, p = 0.021

UCLA x Gender Interaction (Model 3):
  beta = 2.6821, SE = 24.7511, p = 0.914

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 35.7105, p = 0.073
  Male (n=77):   beta = 19.1377, p = 0.371

Diagnostics:
  VIF max: 2.63
  Breusch-Pagan p: 0.728
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 150, correct) (N = 190)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0033, p = 0.895
  Step 2 (UCLA):        Delta R^2 = 0.0063, p = 0.280 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.911 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -20.5867, SE = 18.9933, t = -1.08, p = 0.278

UCLA x Gender Interaction (Model 3):
  beta = 3.4471, SE = 30.8089, p = 0.911

Gender-Stratified UCLA Effects:
  Female (n=113): beta = -23.6242, p = 0.332
  Male (n=77):   beta = -10.4002, p = 0.751

Diagnostics:
  VIF max: 2.63
  Breusch-Pagan p: 0.671
  Shapiro-Wilk p: 0.004


Outcome: PRP Ex-Gaussian mu (SOA 300, correct) (N = 198)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0473, p = 0.020
  Step 2 (UCLA):        Delta R^2 = 0.0006, p = 0.752 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0077, p = 0.328 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -10.5064, SE = 33.1350, t = -0.32, p = 0.751

UCLA x Gender Interaction (Model 3):
  beta = 54.1446, SE = 55.2508, p = 0.327

Gender-Stratified UCLA Effects:
  Female (n=120): beta = -17.1341, p = 0.659
  Male (n=78):   beta = -16.3003, p = 0.807

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.068
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 300, correct) (N = 198)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0441, p = 0.033
  Step 2 (UCLA):        Delta R^2 = 0.0007, p = 0.716 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0063, p = 0.325 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -5.2225, SE = 14.3398, t = -0.36, p = 0.716

UCLA x Gender Interaction (Model 3):
  beta = 22.7688, SE = 23.0564, p = 0.323

Gender-Stratified UCLA Effects:
  Female (n=120): beta = -10.6915, p = 0.557
  Male (n=78):   beta = -3.2232, p = 0.898

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.093
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 300, correct) (N = 198)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0287, p = 0.126
  Step 2 (UCLA):        Delta R^2 = 0.0011, p = 0.653 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.917 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.6861, SE = 17.0545, t = 0.45, p = 0.652

UCLA x Gender Interaction (Model 3):
  beta = 2.7522, SE = 26.3756, p = 0.917

Gender-Stratified UCLA Effects:
  Female (n=120): beta = 8.0545, p = 0.711
  Male (n=78):   beta = 6.6973, p = 0.834

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.548
  Shapiro-Wilk p: 0.239


Outcome: PRP Ex-Gaussian mu (SOA 600, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0203, p = 0.263
  Step 2 (UCLA):        Delta R^2 = 0.0108, p = 0.100 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0103, p = 0.239 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -28.3428, SE = 17.1387, t = -1.65, p = 0.098

UCLA x Gender Interaction (Model 3):
  beta = 41.2406, SE = 34.9083, p = 0.237

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -24.0411, p = 0.304
  Male (n=79):   beta = -51.7917, p = 0.081

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.108
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 600, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0077, p = 0.691
  Step 2 (UCLA):        Delta R^2 = 0.0251, p = 0.013 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0042, p = 0.476 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -21.9682, SE = 8.7655, t = -2.51, p = 0.012

UCLA x Gender Interaction (Model 3):
  beta = 13.3832, SE = 18.7339, p = 0.475

Gender-Stratified UCLA Effects:
  Female (n=115): beta = -17.0023, p = 0.170
  Male (n=79):   beta = -37.9742, p = 0.012

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.171
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 600, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0220, p = 0.235
  Step 2 (UCLA):        Delta R^2 = 0.0093, p = 0.208 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.853 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 20.0034, SE = 15.8445, t = 1.26, p = 0.207

UCLA x Gender Interaction (Model 3):
  beta = 4.4364, SE = 23.9567, p = 0.853

Gender-Stratified UCLA Effects:
  Female (n=115): beta = 12.0332, p = 0.540
  Male (n=79):   beta = 31.3017, p = 0.250

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.524
  Shapiro-Wilk p: 0.085


Outcome: PRP Ex-Gaussian mu (SOA 1200, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0320, p = 0.101
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.615 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0051, p = 0.403 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 6.4459, SE = 12.7812, t = 0.50, p = 0.614

UCLA x Gender Interaction (Model 3):
  beta = 19.2138, SE = 22.9366, p = 0.402

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 4.4523, p = 0.794
  Male (n=80):   beta = 1.9090, p = 0.925

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.410
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian sigma (SOA 1200, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0382, p = 0.060
  Step 2 (UCLA):        Delta R^2 = 0.0037, p = 0.379 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0021, p = 0.521 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 5.0384, SE = 5.7169, t = 0.88, p = 0.378

UCLA x Gender Interaction (Model 3):
  beta = 5.6577, SE = 8.8066, p = 0.521

Gender-Stratified UCLA Effects:
  Female (n=114): beta = 0.7859, p = 0.917
  Male (n=80):   beta = 9.6943, p = 0.282

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.795
  Shapiro-Wilk p: < 0.001


Outcome: PRP Ex-Gaussian tau (SOA 1200, correct) (N = 194)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0195, p = 0.286
  Step 2 (UCLA):        Delta R^2 = 0.0016, p = 0.578 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0001, p = 0.911 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -7.3510, SE = 13.1915, t = -0.56, p = 0.577

UCLA x Gender Interaction (Model 3):
  beta = 2.3700, SE = 21.1455, p = 0.911

Gender-Stratified UCLA Effects:
  Female (n=114): beta = -3.3205, p = 0.850
  Male (n=80):   beta = -16.7036, p = 0.436

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.866
  Shapiro-Wilk p: < 0.001


Outcome: PRP Delta Plot Slope (Bottleneck, correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0086, p = 0.655
  Step 2 (UCLA):        Delta R^2 = 0.0088, p = 0.169 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0002, p = 0.830 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 31.1579, SE = 22.5424, t = 1.38, p = 0.167

UCLA x Gender Interaction (Model 3):
  beta = -7.0109, SE = 32.6745, p = 0.830

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 34.4297, p = 0.232
  Male (n=80):   beta = 26.8371, p = 0.501

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.610
  Shapiro-Wilk p: 0.171


Outcome: PRP Vincentile Bottleneck p10 (correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0076, p = 0.659
  Step 2 (UCLA):        Delta R^2 = 0.0013, p = 0.630 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0073, p = 0.241 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 7.3096, SE = 15.1706, t = 0.48, p = 0.630

UCLA x Gender Interaction (Model 3):
  beta = 25.5324, SE = 21.7162, p = 0.240

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 1.7865, p = 0.919
  Male (n=80):   beta = 7.0689, p = 0.793

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.536
  Shapiro-Wilk p: 0.078


Outcome: PRP Vincentile Bottleneck p30 (correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0137, p = 0.400
  Step 2 (UCLA):        Delta R^2 = 0.0035, p = 0.454 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0228, p = 0.056 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 13.6479, SE = 18.1851, t = 0.75, p = 0.453

UCLA x Gender Interaction (Model 3):
  beta = 52.2076, SE = 27.1950, p = 0.055

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 2.6148, p = 0.900
  Male (n=80):   beta = 11.3863, p = 0.709

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.368
  Shapiro-Wilk p: 0.014


Outcome: PRP Vincentile Bottleneck p50 (correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0150, p = 0.361
  Step 2 (UCLA):        Delta R^2 = 0.0116, p = 0.140 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0163, p = 0.127 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 27.1103, SE = 18.2864, t = 1.48, p = 0.138

UCLA x Gender Interaction (Model 3):
  beta = 48.0806, SE = 31.3238, p = 0.125

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 19.6071, p = 0.374
  Male (n=80):   beta = 15.0559, p = 0.621

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.836
  Shapiro-Wilk p: 0.009


Outcome: PRP Vincentile Bottleneck p70 (correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0057, p = 0.768
  Step 2 (UCLA):        Delta R^2 = 0.0267, p = 0.021 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0185, p = 0.068 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 42.1477, SE = 18.1308, t = 2.32, p = 0.020

UCLA x Gender Interaction (Model 3):
  beta = 52.5120, SE = 28.6037, p = 0.066

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 32.1813, p = 0.146
  Male (n=80):   beta = 33.6896, p = 0.231

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.656
  Shapiro-Wilk p: 0.190


Outcome: PRP Vincentile Bottleneck p90 (correct) (N = 193)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0050, p = 0.809
  Step 2 (UCLA):        Delta R^2 = 0.0126, p = 0.101 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0013, p = 0.583 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 38.4676, SE = 23.3671, t = 1.65, p = 0.100

UCLA x Gender Interaction (Model 3):
  beta = 18.5215, SE = 33.6651, p = 0.582

Gender-Stratified UCLA Effects:
  Female (n=113): beta = 36.2162, p = 0.236
  Male (n=80):   beta = 33.9060, p = 0.369

Diagnostics:
  VIF max: 2.59
  Breusch-Pagan p: 0.676
  Shapiro-Wilk p: 0.650


Outcome: PRP Shape Linear Slope (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0032, p = 0.873
  Step 2 (UCLA):        Delta R^2 = 0.0112, p = 0.125 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0141, p = 0.103 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0204, SE = 0.0132, t = -1.54, p = 0.123

UCLA x Gender Interaction (Model 3):
  beta = -0.0339, SE = 0.0207, p = 0.101

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0146, p = 0.387
  Male (n=82):   beta = -0.0187, p = 0.375

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.807
  Shapiro-Wilk p: 0.128


Outcome: PRP Shape Linear Intercept (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0146, p = 0.358
  Step 2 (UCLA):        Delta R^2 = 0.0020, p = 0.535 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0104, p = 0.201 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 16.8117, SE = 27.0333, t = 0.62, p = 0.534

UCLA x Gender Interaction (Model 3):
  beta = 56.8754, SE = 44.3266, p = 0.199

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 15.1867, p = 0.656
  Male (n=82):   beta = -1.7388, p = 0.970

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.847
  Shapiro-Wilk p: 0.026


Outcome: PRP Shape Linear R-squared (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0057, p = 0.747
  Step 2 (UCLA):        Delta R^2 = 0.0003, p = 0.832 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0006, p = 0.754 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0021, SE = 0.0100, t = 0.21, p = 0.831

UCLA x Gender Interaction (Model 3):
  beta = 0.0046, SE = 0.0147, p = 0.753

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0070, p = 0.465
  Male (n=82):   beta = -0.0091, p = 0.679

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.693
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp Amplitude (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0050, p = 0.773
  Step 2 (UCLA):        Delta R^2 = 0.0018, p = 0.572 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0146, p = 0.093 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 22.6132, SE = 39.9290, t = 0.57, p = 0.571

UCLA x Gender Interaction (Model 3):
  beta = 94.5207, SE = 56.0001, p = 0.091

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -6.9439, p = 0.879
  Male (n=82):   beta = 43.4699, p = 0.541

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.376
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp Decay Rate (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0082, p = 0.628
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.767 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0003, p = 0.841 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0000, SE = 0.0001, t = 0.30, p = 0.767

UCLA x Gender Interaction (Model 3):
  beta = 0.0000, SE = 0.0002, p = 0.841

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0000, p = 0.792
  Male (n=82):   beta = 0.0002, p = 0.420

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.904
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp Asymptote (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0209, p = 0.221
  Step 2 (UCLA):        Delta R^2 = 0.0000, p = 0.993 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0019, p = 0.608 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.2524, SE = 29.2973, t = 0.01, p = 0.993

UCLA x Gender Interaction (Model 3):
  beta = -25.9366, SE = 50.4774, p = 0.607

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 20.8318, p = 0.542
  Male (n=82):   beta = -27.0349, p = 0.633

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.503
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Exp R-squared (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0017, p = 0.951
  Step 2 (UCLA):        Delta R^2 = 0.0082, p = 0.199 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0042, p = 0.379 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0093, SE = 0.0072, t = 1.29, p = 0.197

UCLA x Gender Interaction (Model 3):
  beta = 0.0099, SE = 0.0113, p = 0.378

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0089, p = 0.150
  Male (n=82):   beta = 0.0080, p = 0.624

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.441
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Recovery Half-life (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0164, p = 0.326
  Step 2 (UCLA):        Delta R^2 = 0.0041, p = 0.389 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0036, p = 0.451 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -41.8975, SE = 48.5734, t = -0.86, p = 0.388

UCLA x Gender Interaction (Model 3):
  beta = 58.1480, SE = 76.9077, p = 0.450

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -65.5739, p = 0.289
  Male (n=82):   beta = -18.3237, p = 0.836

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.641
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape Bottleneck (Short-Long) (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0030, p = 0.886
  Step 2 (UCLA):        Delta R^2 = 0.0123, p = 0.126 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0157, p = 0.087 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 24.7373, SE = 16.0799, t = 1.54, p = 0.124

UCLA x Gender Interaction (Model 3):
  beta = 41.4669, SE = 24.1189, p = 0.086

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 19.4878, p = 0.332
  Male (n=82):   beta = 20.5570, p = 0.429

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.818
  Shapiro-Wilk p: 0.129


Outcome: PRP Shape Exp Better Fit (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = 0.0115, p = 0.510
  Step 2 (UCLA):        Delta R^2 = 0.0005, p = 0.773 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = 0.0027, p = 0.488 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = -0.0109, SE = 0.0378, t = -0.29, p = 0.773

UCLA x Gender Interaction (Model 3):
  beta = -0.0386, SE = 0.0555, p = 0.487

Gender-Stratified UCLA Effects:
  Female (n=123): beta = 0.0251, p = 0.532
  Male (n=82):   beta = -0.0696, p = 0.367

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: 0.772
  Shapiro-Wilk p: < 0.001


Outcome: PRP Shape SOA Count (N = 205)
--------------------------------------------------

Model Comparison:
  Step 1 (DASS):        Delta R^2 = nan, p = < 0.001
  Step 2 (UCLA):        Delta R^2 = nan, p = < 0.001 (HC3 Wald)
  Step 3 (Interaction): Delta R^2 = nan, p = 0.437 (HC3 Wald)

UCLA Main Effect (Model 2):
  beta = 0.0000, SE = 0.0000, t = 4.84, p = < 0.001

UCLA x Gender Interaction (Model 3):
  beta = -0.0000, SE = 0.0000, p = 0.436

Gender-Stratified UCLA Effects:
  Female (n=123): beta = -0.0000, p = 0.225
  Male (n=82):   beta = 0.0000, p = 0.783

Diagnostics:
  VIF max: 2.61
  Breusch-Pagan p: < 0.001
  Shapiro-Wilk p: < 0.001

======================================================================
Note. HC3 robust standard errors used for all tests.
======================================================================